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Table no: 18 Table showing Summary of results of method validation for 
Codeine phosphate, Chlorpheniramine maleate and Sodium Benzoate 
 
S.No Parameter Requirement Results Acceptance criteria 
   CP CPM SB  
1. 
System 
suitability 
RT    7.148 9.469 10.861  
2. Tailing factor 1.1 1.0      1.1 NMT 2 
3. Resolution      11.7 8.6 NLT 2 
4. Plate count 16091.54 58142.60 63875.82 NLT 3000 
5.  Assay value 99.2% 101.2% 99.8% 100 ± 2.0% 
6. Accuracy % Recovery 98.7% 98.5% 99.1% 100 ± 2.0% 
7. Precision %RSD 0.43 0.36 0.39 NMT 2% 
8. Specificity  No interference  
Pass Pass Pass No interference
8. Linearity Correlation coefficient 0.999991 0.999980 0.999943 NLT 0.999 
9. Range Concentration 12.5-75 µg/ml 
5-30 
µg/ml 
12.5-75 
µg/ml Nil 
10. Robustness %RSD 0.41 0.38 0.39 NMT 1% 
11. Ruggedness %RSD 0.55 0.34 0.64 NMT 1% 
ABSTRACT 
 
 
                         A  simple,  specific,  accurate  and  stability-indicating  reversed  phase  high  
performance  liquid chromatographic method was developed for the simultaneous 
determination of Codeine phosphate, Chlorpheniramine maleate and Sodium benzoate in 
cough syrup formulation.By Zodiac C-18, 3.5µ,150×4.6mm column eluted with Solvent-A: 
Phosphate buffer pH-2.3, Solvent-B: Acetonitrile  by gradient elution pattern at a flow rate of 
1.5 ml/ min and a detection wavelength of 254 nm with injection volume of 50 μl at 
Ambient(30°C) temperature afforded the best separation of these analytes. The retention 
times of Codeine phosphate, Chlorpheniramine maleate and Sodium benzoate were found to 
be 7 . 1 8 min, 9.469 min and 10.86 min respectively. The system precision of this method 
was evaluated by calculating the %RSD of the peak areas of six replicate injections of the 
standard solution, which were found to be 0.41%, 0.35% and 0.37%.Accuracy studies were 
performed where the % Recovery of three drugs was found to be 98.7%, 98.5% and 99.1% 
respectively. Linearity was established for Codeine phosphate, Chlorpheniramine maleate 
and Sodium benzoate in the range of 12.5-75 μg/ml, 5-30 μg/ml and 12.5-75 μg/ml 
respectively. Specificity of the current method was demonstrated by good separation of the 
three analytes from each other. Furthermore, excipients of the formulation did not interfere 
with the active ingredients of the drug product. Robustness of the current method was 
investigated by analyzing samples of the drug product using the same chromatographic 
conditions set forth in method development but with a small change in the following 
chromatographic parameters: Flow rate: 1.4 and 1.6 ml/min instead of 1.5 ml/min and pH of 
the buffer preparation in mobile phase: 2.2 and 2.4 instead of 2.3.The %RSD’s were found to 
be within the limits.  Ruggedness was demonstrated by analyzing three samples (assay) of 
syrup formulation by two analysts in the same laboratory on two different days. The %RSD 
values for the 12 samples are calculated to be 0.42%, 0.62%, and 0.49% for Codeine 
phosphate, Chlorpheniramine maleate and Sodium benzoate respectively. The analytical 
procedure is validated as per ICH Q2B guidelines and shown to be accurate, precise and 
specific. This method is amenable to the routine analysis and can be successfully employed 
for simultaneous quantitative analysis of Codeine phosphate, Chlorpheniramine maleate and 
Sodium benzoate respectively in bulk drugs and formulations. 
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1. INTRODUCTION 
   1.1 PHARMACEUTICAL ANALYSIS: 
   
            Pharmaceutical Analysis is the branch of science which deals with 
identification of substances and determination of amount present in particular sample. 
Also pharmaceutical analysis deals with bulk materials, dosage forms and more 
recently, biological samples in support of bio-pharmaceutical and pharmacokinetic 
studies.  
              Analysis can be divided into areas called qualitative and quantitative 
analysis. Pharmaceutical products synthesized and identified using instrumental 
techniques.1  
             These methods are used extensively in the quality assurance of raw materials, 
in process quality assessment, stability of the drugs on storage and monitoring drugs 
concentrations in various body fluids or tissues.  
 
The types of analysis can be distinguished in two ways:   
 
A. QUALITATIVE ANALYSIS: To refer identity of product, i.e., it yields useful 
clues from which the molecular or atomic species, the structural features, or the 
functional groups in the sample can be identified.  
 
B. QUANTITATIVE ANALYSIS: To refer the purity of the product, i.e., the results 
are in the form of numerical data corresponding to the concentration of analytes.  
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TYPES OF ANALYTICAL METHODS  
The various methods of analysis 3 can be grouped into two categories. They are:  
1. Chemical methods.  
2. Instrumental methods.  
Chemical Methods:  
In these methods, volume and mass are used as means of detection.  
1. Titrimetrical methods like acid-base, oxidation-reduction, non-aqueous, 
complexometric, precipitation titrations.  
2. Gravimetric and thermo gravimetric methods.  
3. Volumetric methods. 
Instrumental Methods:  
These methods are based on the measurement of specific and non-specific physical 
properties of a substance as given below: 
Different Instrumental Methods Based On Principles 
Table No: 1 Table showing list of instrumental methods. 
S.No. Principle Instrument Method 
1. Emission of radiation. X-ray emission spectrometry. Fluorescence 
spectrometry 
2. Absorption of radiation. UV/Visible ,I.R Spectrophotometry, NMR 
Spectroscopy,ESR Spectroscopy, Atomic 
absorption spectrometry 
3. Mass to charge ratio. Mass spectrometry 
4. Refraction of radiation. Refractometry 
5. Scattering of radiation. Nephelometry 
6. Rotation of radiation. Polarimetry 
7. Electrical potential. Potentiometry 
8. Electrical current. Amperometry, Polargraphy 
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9. Electrical resistance. Conductometry 
10. Thermal properties. Differential thermal analysis, Differential 
Scanning Calorimetry, Thermogravimetry 
11. Partition / Adsorption. Chromatographic Techniques. 
 
1.2 CHROMATOGRAPHY:  
Chromatography (from Greek chroma, color and graphein to write) is the 
collective term for a set of laboratory techniques for the separation of mixtures. It 
involves passing a mixture dissolved in a "mobile phase" through a stationary phase, 
which separates the analyte to be measured from other molecules in the mixture based 
on differential partitioning between the mobile and stationary phases. Subtle 
differences in a compound's partition coefficient result in differential retention on the 
stationary phase and thus changing the separation. Chromatography may be 
preparative or analytical. The purpose of preparative chromatography is to separate 
the components of a mixture for further use (and is thus a form of purification). 
Analytical chromatography is done normally with smaller amounts of material and is 
for measuring the relative proportions of analytes in a mixture. The two are not 
mutually exclusive. 
The history of chromatography begins during the mid-19th century. 
Chromatography, literally "color writing", was used and named in the first decade of 
the 20th century, primarily for the separation of plant pigments such as chlorophyll. 
New types of chromatography developed during the 1930s and 1940s made the 
technique useful for many types of separation process. Some related techniques were 
developed during the 19th century (and even before), but the first true 
chromatography.  
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Chromatography terms 
• The analyte is the substance to be separated during chromatography.  
• Analytical chromatography is used to determine the existence and possibly 
also the concentration of analyte(s) in a sample.  
• A bonded phase is a stationary phase that is covalently bonded to the support 
particles or to the inside wall of the column tubing.  
• A chromatogram is the visual output of the chromatograph. In the case of an 
optimal separation, different peaks or patterns on the chromatogram 
correspond to different components of the separated mixture.  
Plotted on the x-axis is the retention time and plotted on the y-axis a signal (for 
example obtained by a spectrophotometer, mass spectrometer or a variety of other 
detectors) corresponding to the response created by the analytes exiting the system. In 
the case of an optimal system the signal is proportional to the concentration of the 
specific analyte separated.  
• A chromatograph is equipment that enables a sophisticated separation e.g. 
gas chromatographic or liquid chromatographic separation.  
• Chromatography is a physical method of separation in which the components 
to be separated are distributed between two phases, one of which is stationary 
(stationary phase) while the other (the mobile phase) moves in a definite 
direction.  
• The eluent is the mobile phase leaving the column.  
• An eluotropic series is a list of solvents ranked according to their eluting 
power.  
• An immobilized phase is a stationary phase which is immobilized on the 
support particles, or on the inner wall of the column tubing.  
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• The mobile phase is the phase which moves in a definite direction. It may be 
a liquid (LC), a gas (GC), or a supercritical fluid (supercritical-fluid 
chromatography, SFC). The mobile phase consists of the sample being 
separated/analyzed and the solvent that moves the sample through the column. 
In the case of HPLC the mobile phase consists of a non-polar solvent(s) such 
as hexane in normal phase or polar solvents in reverse phase chromatography 
and the sample being separated. The mobile phase moves through the 
chromatography column (the stationary phase) where the sample interacts with 
the stationary phase and is separated.  
• Preparative chromatography is used to purify sufficient quantities of a 
substance for further use, rather than analysis.  
• The retention time is the characteristic time it takes for a particular analyte to 
pass through the system (from the column inlet to the detector) under set 
conditions.  
• The sample is the matter analyzed in chromatography. It may consist of a 
single component or it may be a mixture of components. When the sample is 
treated in the course of an analysis, the phase or the phases containing the 
analytes of interest is/are referred to as the sample whereas everything out of 
interest separated from the sample before or in the course of the analysis is 
referred to as waste.  
• The solute refers to the sample components in partition chromatography.  
• The solvent refers to any substance capable of solubilizing other substance, 
and especially the liquid mobile phase in LC.  
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• The stationary phase is the substance which is fixed in place for the 
chromatography procedure. Examples include the silica layer in thin layer 
chromatography.  
• Techniques by chromatographic bed shape:  
o Column chromatography  
o Planar chromatography  
 Paper chromatography  
 Thin layer chromatography  
• Displacement chromatography  
• Techniques by physical state of mobile phase:  
o Gas chromatography  
o Liquid chromatography  
• Affinity chromatography  
o   Supercritical fluid chromatography  
• Techniques by separation mechanism:  
o  Ion exchange chromatography  
o  Size exclusion chromatography  
• Special techniques:  
o  Reversed-phase chromatography  
o Two-dimensional chromatography  
o Simulated moving-bed chromatography  
o Pyrolysis gas chromatography  
o Fast protein liquid chromatography  
o Countercurrent chromatography  
o Chiral chromatography 
Chapter 1                                                                                                       Introduction 
Rvs College Of Pharmaceutical Sciences, Coimbatore  Page 7 
   
1.3 HIGH PERFORMANCE LIQUID CHROMATOGRAPHY: 
                High Pressure Liquid Chromatography (HPLC) 5, sometimes called High   
Performance liquid chromatography, is a separation that can be used for the analysis 
of organic molecules and ions. HPLC is based on mechanisms of adsorption, 
partition, ion exchange or size exclusion, depending on the type of stationary phase 
used. HPLC involves a solid stationary phase, normally packed inside a stainless-steel 
column, and a liquid mobile phase. Separation of the components of a solution results 
from the difference in the relative distribution ratios of the solutes between the two 
phases. 
   The rate of distribution of drugs between stationary and mobile phase 
is controlled by diffusion process, if diffusion is minimized, a faster and effective 
separation can be achieved. The techniques of HPLC are so called because of its 
improved performance when compared to classical column chromatography. 
Advances in column technology, high pressure pumping system and sensitive 
detectors have transformed liquid column chromatography into high speed, efficient, 
accurate and highly resolved method of separation. 6  
               HPLC is a form of column chromatography used frequently in biochemistry 
and analytical chemistry to separate, identify, and quantify compounds. HPLC utilizes 
a column that holds chromatographic packing material (stationary phase), a pump that 
moves the mobile phase(s) through the column, and a detector that shows the 
retention times of the molecules. Retention time varies depending on the interactions 
between the stationary phase, the molecules being analyzed and the solvent(s) used. 7  
It offers following advantages: 
-   Speed (many analysis can be accomplished in 20 minutes or less) 
-  Greater sensitivity (various detectors can be employed) 
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-   Reusable columns (expensive columns but can be used for many analysis) 
-   Ideal for the substances of low volatility. 
-   Easy sample recovery, handling and maintenance. 
-   Instrumentation leads itself to automation and quantitation.  
-   Precise and reproducible. 
-   Calculations are done by integrator itself. 
-   Suitable for preparative liquid chromatography on a much larger scale. 
TYPES OF HPLC 8: 
 Based on the mode of separation 
•    Normal phase chromatography 
• Reverse phase chromatography 
• Partition chromatography 
• Displacement chromatography 
 Based on principle of separation 
• Adsorption chromatography 
• Ion exchange chromatography  
• Size exclusion chromatography  
• Affinity chromatography  
• Chiral phase chromatography  
• Ion pair chromatography 
 Based on elution technique 
• Isocratic separation 
• Gradient separation  
 Based on the scale of operation 
• Analytical HPLC 
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• Preparative HPLC 
Based on the mode of separation: 
Normal phase chromatography:    
              Also known as Normal phase HPLC (NP-HPLC) or Adsorption 
chromatography, separate analytes based on adsorption to a stationary surface 
chemistry and by polarity. It was one of the first kinds of HPLC that chemists 
developed. In this type stationary phase used is polar in nature and the mobile phase 
used is non-polar and non aqueous in nature. Depending on the nature of the analyte 
and stationary phase. If the affinity between the stationary phase and the analyte 
increases the selection time (RT) of the analyte also increases and vice versa. The 
interaction strength depends not only on the functional groups in the analyte molecule 
but also on steric factors. The effect of sterics on interaction strength allows this 
method to resolve (separate) structural isomers. 
Reverse phase chromatography 
               In reverse phase technique, a non-polar stationary phase is used and the mobile 
phase is polar in nature. Hence polar components get eluted first and non-polar 
compounds are retained for a longer time. Since most of the drugs and 
pharmaceuticals are polar in nature, they are not retained for a longer time and eluted 
faster, columns used in the mode of chromatogram are ODS (Octadecyl silane) or C18, 
C8, C4, etc. 
Partition chromatography 
               Partition chromatography was the first kind of chromatography that chemists 
developed. The partition coefficient principle has been applied in paper 
chromatography, thin layer chromatography, gas phase and liquid-liquid applications. 
Partition chromatography uses a retained solvent, on the surface or within the grains 
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or fibers of an "inert" solid supporting matrix as with paper chromatography; or takes 
advantage of some additional columbic and/or hydrogen donor interaction with the 
solid support. Molecules equilibrate (partition) between a liquid stationary phase and 
the eluent separate analytes based on the polar differences is known as Hydrophilic 
Interaction Chromatography (HILIC). Partition HPLC has been used historically on 
unbonded silica or alumina supports. Each works effectively for separating analytes 
by relative polar differences. However, HILIC has the advantage of separating acidic, 
basic and neutral solutes in a single chromatogram. 
Displacement Chromatography 
               The basic principle of displacement chromatography is a molecule with a 
high affinity for the chromatography matrix (the displacer) will compete effectively 
for binding sites and thus displace all molecules with lesser affinities. In elution 
mode, substances typically emerge from a column in narrow Gaussian peaks. Wide 
separation of peaks, preferably to baseline, is desired in order to achieve maximum 
purification. The speed at which any component of a mixture travels down the column 
in elution mode depends on many factors. But for two substances to travel at different 
speeds and thereby be resolved there must be substantial differences in some 
interaction between the bio molecules and the chromatography matrix. Operating 
parameters are adjusted to maximize the effect of this difference. In many cases, 
baseline separation of the peaks can be achieved only with gradient elution and low 
column loadings. Thus, two drawbacks to elution mode chromatography, especially at 
the preparative scale, are operational complexity, due to gradient solvent pumping, 
and low throughput, due to low column loadings. Displacement chromatography has 
advantages4 over elution chromatography in that components are resolved into 
consecutive zones of pure substances rather than “peaks”. 
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Based on principle of separation: 
Adsorption chromatography: 
            When a mixture of compounds (adsorbate) dissolved in the mobile phase 
(eluent) moves through a column of stationary phase (adsorbent) they travel 
according to their relative affinities. The compound which has more affinity towards 
stationary phase travels slower, if less affinity towards stationary phase travels faster. 
Ion exchange chromatography: 
                It is the process by which a mixture of similar charged ions can be separated 
using ion exchange resin. There is a reversible exchange of ions between the ions 
present in the column. And those present in the ion exchange resin. For cations, cation 
exchange resin and for anions, an anion exchange resin is used. 
        1) Cation exchange eg: Sulfonated polystyrenes 
        2) Anion exchange resin eg: Carboxylic methacrylate 
Size exclusion chromatography: 
               It is the process by which mixture of compounds with molecular sizes are 
separated by using gels. The gel used acts as molecular sieve. It can be separated by 
steric and diffusion effects of pores in the gels. The compound can separate according 
to the molecular sizes and the stationary phase is a porous matrix. 
         Eg: separation of proteins and polysaccharides. 
Chiral phase chromatography: 
              In this type of chromatography, separation of optical isomers can be done by 
using chiral stationary phases i.e., levo and dextro form can be separated by using 
chiral stationary phases. Eg: chemically bonded silica gel. 
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Ion pair chromatography: 
In this chromatography, a reverse phase column is converted temporarily into 
ion exchange column by using ion pairing agents like pentane or hexane. 
Based on the scale of operation: 
Analytical HPLC: It is used for analysis of samples. But recovery of samples is not 
done since the samples used are at very low level. Eg: microgram quantities. 
Preparative HPLC: It is used for separation and collection of compound mixture, 
where the individual and pure compounds can be collected using fraction collector. 
And the collector samples are reused. Eg: separation of few grams of mixtures. 
INSTRUMENTATION OF HPLC 9:  
The main components of HPLC are:  
• Solvent Reservoir 
• Pump 
• Injection Port 
• Column 
• Detector 
• Data Acquisition System 
                     
Fig. No. 1: Figure showing Systematic diagram of HPLC. 
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Solvent Reservoir: 
  Solvent Reservoirs are used to store Mobile-Phase. Scott Duran bottles are 
commonly used as solvent reservoirs. The solvent reservoir must be made of inert 
material such as glass and must be smooth so as to avoid growth of microorganisms 
on its walls. It can be transparent or can be amber colored. A graduated bottle gives a 
rough estimate of mobile-phase volume in the bottle. Solvent reservoirs are placed 
above HPLC system (at higher level) in a tray. They should never be kept directly 
above the system as any spillage of solvent on the system may damage electronic 
parts of HPLC.  
HPLC Pump: 
  The HPLC pump is very important component of the system. The 
Pump delivers the constant flow of the Mobile Phase or phases so that the separation 
of the components of the mixture occurs in a reasonable time. There are two types of 
pumping systems Isocratic and Gradient. The gradient type pumps also classified into 
two types, those are: 
• High pressure mixing. Eg: Mechanical and Piston pumps. 
• Low pressure mixing. Eg:  Pneumatic and Quaternary pumps. 
Injection Port 10: 
  The sample introduction device such as injector is to introduce the sample in a 
flow of mobile phase at high pressure. The valve injection through fixed or variable 
loop is a common way of introducing the sample. The Rheodyne valve is the mostly 
used devise.  
HPLC Column: 
  The HPLC Column holds the stationary phase for separating the components 
of the sample. The columns are usually made up of SS-316 grade steel. Apart from 
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columns, the material of construction of tubing and fittings, plumbing and 
connections are also very critical. Apart from resistively to corrosion, connections and 
plumbing should have very low dead volume. 
 
Table no: 2 list of column selection chart. 
 
Stationary phases: 11 
There are many types of stationary phases employed in liquid chromatography 
including: 
(1) Silica, alumina or porous graphite is used in normal-phase chromatography 
where the separation is based on differences in adsorption and/or mass 
distribution.  
(2) Resins or polymers with acid or basic groups, used in ion-exchange 
chromatography, where separation is based on competition between the ions 
to be separated and those in the mobile phase. 
(3) Porous silica or polymers, used in size-exclusion chromatography, where 
separation is based on differences between the volumes of the molecules, 
corresponding to steric exclusion. 
(4) A variety of chemically modified supports prepared from polymers, silica or 
porous graphite, used in reversed-phase liquid chromatography, where the 
separation is based principally on partition of the molecules between the 
mobile phase and the stationary phase. 
Column selection chart: molecular weight > 2000 g/mol 
 Water soluble Organic solvent 
soluble 
LC mode  
(packing) 
RP 
bonded 
(C18, 
phenyl, 
C4) 
aqueous 
gel 
filtration 
(SEC) 
Ion 
exchange
hydrophobic 
interaction 
affinity size exclusion 
chromatography 
Chapter 1                                                                                                       Introduction 
Rvs College Of Pharmaceutical Sciences, Coimbatore  Page 15 
   
(5) Special chemically modified stationary phases, for example cellulose or 
amylase derivatives, proteins or peptides, cyclodextrins etc., for the 
separation of enantiomers (chiral chromatography). 
HPLC Detectors: 12  
  Detectors detect various compounds as they elute out from column. The 
detector gives response in terms of a millivolt (mv) signal that is then processed by 
the computer (integrator) to obtain you a chromatogram. Basically detector consists of 
a flow-cell through which the mobile phase and resolved sample moves optic shine 
through the detector cell and variation in optical properties are detected.  
  The Photo Diode Array Detector (PDA) is the most used detector in LC 
today.  The PDA gives a three dimensional view of chromatogram (Intensity Vs 
Time) and Spectra (Intensity Vs Wavelength) simultaneously. It can be called as 
Spectro-chromatogram. The detailed analysis of the data reveals more information on 
the complexity of co elution and helps in identifying the merged peaks and gives 
information on peak purity. 
Various types of HPLC Detectors: 
 There are several types of detectors available in the market. Those are  
• UV-VIS Detector 
• Photo-Diode Array Detector (PDA) 
• Fluorescence Detector 
• Conductometric and colorimetric detector 
• Mass detector 
• Evaporative Light Scattering detector (ELSD) 
        Among these detectors Photo Diode Array Detector (PDA) is the most widely 
used detector.  The PDA gives a three dimensional view of chromatogram (Intensity 
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Vs Time) and Spectra (Intensity Vs Wavelength) simultaneously. It can be called as 
Spectro-chromatogram. The detailed analysis of the data reveals more information on 
the complexity of co elution and helps in identifying the merged peaks and gives 
information on peak purity. 
Ideal Characteristics of a Detector: 
• Either is equally sensitive to all eluted peaks. 
• The ideal detector give the response (area) proportional to the amount 
injected, irrespective of the size of sample. 
• Cheap, reliable and easy to use.  
• Should not be affected by change in temperature or mobile phase 
composition.  
• It should be able to monitor small amounts of compound. 
i. Bulk property detector:  
These provide a differential measurement of bulk property possessed by 
both the solute and mobile phase Ex: Refractive index. It is not suitable for 
gradient elution and is less sensitive.  
ii. Solute property detector:  
This measures physical or chemical property that is specific to the solute    
only. Ex: U.V detector, conductivity detector. These can be used for gradient 
elution. 
The detection of the separated compounds in the elute from the column is based 
up on the bulk properties of the elute are the solute property of the individual 
components generally, a detector is selected that will respond to a particular property 
of the substances being separated, and ideally it should be sensitive to at least 10-8g 
ml-1 and give a linear response over a wide concentration range. 
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Data collection devices: 
             Signals from the detector may be collected on chart recorders or electronic 
integrators that vary in complexity and in their ability to process, store and reprocess 
chromatographic data. The data storage capacity of these devices is usually limited. 
              Modern data stations are computer based and have a large storage capacity to 
collect process and store data for possible subsequent reprocessing. Analytical reports 
can often be customized to the needs of the analyst. 
              Integration of peak areas and the setting of threshold levels are not normally 
problematic in an assay since the peak of the substance to be analysed should be free 
of interference. However, in a test for impurities, the selection of the peak area 
integrator parameters becomes very important, particularly when baseline separations 
are not always attainable. If baseline separations cannot be obtained, valley-to-valley 
integration should be employed. 
           HPLC allows limits to be set for individual impurities and for the sum of 
impurities, but there is a level at which peaks should not be integrated. This 
"disregard level" is set in relation to the area of the peak in the chromatogram of the 
prescribed reference solution and is usually equivalent to 0.05% of the substance 
being examined. 
CHROMATOGRAPHY PARAMETERS 13: 
 System suitability: 
  The system suitability test represents an integral part of the method and is used 
to ensure the adequate performance of the chosen chromatographic system. 
Efficiency, capacity factor resolution factor, and symmetry factor are the 
parameters that are normally used in assessing the column performance. Factors that 
can affect chromatographic behavior include mobile phase composition, temperature, 
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ionic strength, apparent pH, flow rate and column length and stationary phase 
characteristics such as porosity, particle size and type, and specific surface area.  
Efficiency (N) 14  : 
The efficiency of a chromatographic column is defined in terms of the number 
of theoretical plates (N) and can be calculated using the following formula: 
 
  
Where, tR = retention time or the baseline distance between the point of injection                 
and the perpendicular dropped from the maximum of the peak of interest. 
Wh = the width of the peak of interest determined at half peak height, measured in the 
same units as tR. 
 N = The number of theoretical plates per meters. 
The column plate number increases with several factors: 
1. Well-packed columns (column “quality”) 
2. Longer columns 
3. Lower flow rates (but not too low) 
4. Smaller column-packing particles 
5. Lower mobile-phase viscosity and higher temperature 
6. Smaller sample molecules. 
Capacity factor (mass distribution ratio, Dm): 
     This factor determines the retention of a solute and can be calculated from                        
the chromatogram using the following formula: 
 
 
Where, tR    = retention time of the solute 
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 tM   =   retention time of an unretained component 
A low Dm value indicates that the peak elutes close to the solvent front, which 
may compromise selectivity. A minimum Dm value of 1 is recommended for the peak 
of interest. 
The retention time of the test substance can be varied, if necessary, by 
changing the relative proportion or composition of solvents in the mobile phase. 
Generally, an increase in the proportion of a more polar solvent will lead to a shorter 
retention time on a normal-phase column and a longer retention time on a reversed-
phase column. 
Resolution factor (Rs): 
 It is measure of the extent of separation of two compounds and the baseline 
separation is achieved. 
The resolution between two peaks of similar height in a chromatogram can be 
calculated using the following formula: 
  
 
Where, tR1 and tR2 = retention times or baseline distances between the point of 
injection and the perpendicular dropped from the maximum of each of the two peaks. 
Wb1 and Wb2 = the respective peak widths determined at half peak height, measured in 
the same units as tR1 and tR2. 
The value of Rs for a baseline separation between peaks of similar height should be at 
least two. 
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Relative retention: 
The relative retention (r) is calculated as an estimate using the following formula: 
 
Where, tR2    = retention time of the peak of interest  
tR1    =   retention time of the reference peak 
tM     =    retention time of an unretained component 
Retention time (Rt): 
Retention time is the difference in time between the points of injection and 
eluted from a column. Retention time is measured in minutes or seconds. Retention 
time is also proportional to the distance moved on a chart paper, which can be 
measured in cm or mm. 
Retention volume (Vr): 
Retention volume is the volume of mobile required to elute 50% of the 
component from the column. It is the product of retention time and flow rate. 
Retention volume (Vr) = Retention time (Rt) x flow rate 
 
 Column Efficiency (N): 
It is called as the number of theoretical plates. It measures the band spreading 
of a peak. When band spread in smaller, the number of theoretical plates is higher. It 
indicates a good column and system performance. 
N=16 (RT / W) 2 
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HETP (High Equivalent Theoretical Plates): 
 A theoretical plate can be of any height, which decides the efficiency of 
separation.  If HETP is less the column is more efficient.  If HETP is more, the 
column is less efficient.  The height equivalent to a theoretical plate (HETP) is given 
by-                          
                                          HETP=Length of column (L)/N  
Where N =   plates per meter 
         RT =   retention time of the components. 
          W =   width of the base of the component peak using tangent method. 
           L =   column length in meters       
Symmetry factor (As): 
The symmetry factor for a peak can be calculated using the following formula:                          
 
 
Where, Wx = width at 5% of peak height measured from the baseline. 
             d = baseline distance between the perpendicular dropped from the peak 
maximum and the leading edge of the peak at 5% of the peak height, measured in the 
same units as Wx.  
Values of As which are greater than 2 may lead to incorrect integration, 
resulting in erroneous quantitation. The main factors that influence peak symmetry 
depend upon retention, solvent effects, incompatibility of the solute with the mobile 
phase or development of an excessive void at the inlet of the column. In reversed-
phase chromatography, adsorption phenomena due to the presence of residual silanol 
groups in the stationary phase may lead to tailing (poor peak symmetry). 
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Tailing Factor (T): 
The Tailing Factor T, a measure of peak symmetry is unity for perfectly 
symmetrical peaks and its value increases as tailing becomes more pronounced. In 
some cases, values less than 1 may be observed. As peak asymmetry increases 
integration and hence precision becomes less reliable. 
 
 
Where, W0.05 = width of peak at 5% height 
f = Distance from the peak maximum to the leading edge of the peak, the distance 
being measured at a point 5% of the peak height from the baseline. Limit: ≤ 2 . 
1.4 METHOD DEVELOPMENT: 
    The need to save method development time and improve accuracy is forcing 
today’s analytical chemists to look for better, faster ways to develop stability 
indicating methods. Starting with HPLC columns that offer excellent reproducibility, 
column lifetime and sensitivity this step-by-step protocol can save the method 
development chemist time and money required to establish new method. This 
approach is consistent with developing process. 
 PROCEDURE (PROTOCOL) FOR METHOD DEVLOPMENT 
 Literature Survey: 
  Conduct literature survey and collect information available from the following 
references 
¾ Chemical abstracts 
¾ Analytical abstracts  
¾ Journals 
¾ National library of medicines etc, 
     T= W0.05 /2f 
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And collect the following literature from survey 
Solubility profile: Solubility of drug in different solvents at different pH conditions 
which is useful while selecting the diluents for standard solution and extraction 
solvents for test solution. 
Analytical profile: Physico-chemical and spectroscopic properties, impurity and 
degradation profile of drug substance. Spectral profile is useful in the selection of 
detector wavelength for analysis, where as degradation profile helps to develop the 
method for separation of all possible impurities and degradants from API. 
Stability profile: Stability of the drug with storage conditions. This helps to adopt 
suitable and adequate precautions while handling drug substances and its solutions. 
The various parameters that include to be optimized during method development are: 
• Selection of Mode of Separation 
• Selection and Optimization of Mobile Phase 
• Selection of Detector Wavelength 
• Selection of Column 
• Selection of Solvent Delivery Systems 
• Selection of Flow Rate 
• Selection of Column Temperature 
• Selection of Diluent and Extraction Procedure 
• Selection of test concentration and injection volume 
• Establishment of Stability of the Solutions 
• Establishment of System Suitability 
Selection of Mode of Separation: 
           In Reverse Phase mode, the mobile phase is comparatively more polar than the 
stationary phase. For the separation of polar or moderately polar compounds, the most 
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preferred mode is reverse phase. The nature of the analyte is the primary factor in the 
selection of the mode of separation. A second factor is the nature of the matrix. 
Selection and Optimization of Mobile Phase: 
        The primary objective in selection and optimization of mobile phase is to 
achieve optimum separation of all individual impurities and degradants from analyte 
peak. The selection of mobile phase is done always in combination with selection of 
column (stationary phase). The following are the parameters, which shall be taken 
into consideration during the selection and optimization of mobile phase. 
¾ Buffer, if any and its strength 
¾ pH of buffer or pH of mobile phase 
¾ Mobile phase composition 
Buffer if any and its strength: 
Buffer and its strength play an important role in deciding the peak symmetries 
and separation. Various types of buffers can be employed for achieving the required 
separation. The following are some of the most commonly used ones. 
¾ Phosphate buffers :   KH2PO4, K2HPO4, Na2HPO4, H3PO4 
¾ Acetate buffers     :   Ammonium acetate, Sodium acetate 
¾ Amine buffers       :   Triethyl amine/ Diethyl amine 
¾ Buffers with various ion pair reagents like Tetra Butyl ammonium hydrogen 
sulphate 
¾ Butane sulphonic acid, Hexane sulphonic acid, Heptanes sulphonic acid etc, 
    It is important to use the buffers with suitable strength to cope up for the 
injection load on the column otherwise peak tailing may arise due to changes in ionic 
form during chromatography. The retention times also depends on the molar strength 
of the buffer since molar strength is inversely proportional to retention time. 
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       Ideally, the strength of the buffer shall be adopted in-between 0.05M to 0.2M. 
The selection of the buffer and its strength is done always in combination with 
selection of organic phase composition in mobile phase. The strength of the buffer can 
be altered if necessary to achieve the required separation. But it has to be ensured that 
the higher strength of the buffer shall not result in precipitation/turbidity either in 
mobile phase or in standard and test solution while allowed standing in bench top or 
in refrigerator. Experiments shall be conducted using different buffers having 
different strength to obtain the required separation. 
 The buffer having a particular strength, which gives separation of all 
individual impurities from API peak, shall be selected. Then strength of the buffer can 
be varied by about 10 to 20 % from the selected buffer strength and the effect of 
variation shall be studied. After reviewing the results of variation, the buffer and its 
strength shall be selected, this is rugged for at least 2% variation in strength. 
pH of the buffer or pH of the mobile phase: 
    pH plays an important role in achieving the chromatographic separation as it 
control the elution properties by controlling the ionization characteristics. Depending 
on the pKa, drug molecule changes retention. 
E.g.: Acids show an increase in retention as pH decreases, while bases show decrease 
in retention time. 
        Experiments shall be conducted using buffers having different pH to obtain 
the required separation. It is important the pH of the mobile phase in the range of 2.0 
to 8.0 as most of the columns doesn’t withstand to a pH outside this range. This is due 
to fact that the siloxane linkages are cleaved below pH 2.0, while at pH values above 
8.0 silica may dissolve. 
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  If a pH outside this range is found necessary, packing materials, which can 
withstand these ranges shall be chosen. pH of the buffer, which gives separation of all 
individual impurities from each other and from API, shall be selected. Then pH is 
varied by ±0.2 from the selected pH and effect of variation shall be studied. After 
reviewing the results, a pH is selected which is rugged at least for ±0.2 of the selected 
pH. 
Mobile phase composition:  
    In reverse phase chromatography, the separation is mainly controlled by the 
hydrophobic interactions between drug molecule and the alkyl chains on the columns 
packing material. Most chromatographic separations can be achieved by choosing the 
qualitative and quantitative composition of aqueous and organic portions. Most 
widely used solvents in reverse phase chromatography are methanol and Acetonitrile. 
Tetra hydro furan is also used but to a lesser extent. 
 Experiments shall be conducted with mobile phase having buffers with 
different pH and organic phases to check for the best separation between the 
impurities. A drug solution having all possible known impurities can be used for 
checking the extent of separations with different mobile phase ratios. Alternatively 
solution of stressed drug substance can be used to check for the separation of 
impurities. A mobile phase composition which gives separation of all possible 
impurities and degradants from API Peak and which is rugged at least for ± 0.5 in 
both aqueous and organic phase shall be selected. 
          In reverse phase, methods are developed using buffers at the specified mobile 
phase pH. Optimum buffering capacity occurs at a pH equal to the pKa of the buffers. 
Also it shows little effect on retention time. Potassium salts are more soluble than 
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sodium salts. Diammonium hydrogen orthophosphate is used as phosphate buffer pH 
2.3 and Acetonitrile. 
Selection of Detector Wavelength: 
    Selection of detector wavelength is a critical step in finalization of the 
analytical method. To determine the exact wavelength standard API is injected into 
chromatographic system with Photo Diode Array detector and the wave length, which 
gives higher response for the compound will be selected. An ideal wavelength is one 
that gives good response for the drugs to be detected. In order to ascertain the 
optimum wavelength  (λmax) of the species formed. A 10µg/ml of sample solution was 
prepared and scanned under UV-visible spectrophotometer in the range of 200 to 
400nm against diluent as blank. The wave length selected based on the maximum 
absorption occurred. 
Selection of Column: 
       Column plays the most important role in achieving the chromatographic 
separation. The following parameters should be considered while selecting a column. 
¾ Length and diameter of the column  
¾ Packing material  
¾ Size and shape of particles 
¾ Pore size, surface area and end capping 
¾ Percentage of carbon loading 
    Columns with silica as a packing material is used widely in Normal phase 
chromatography, where the eluent (mobile phase) is non-polar consisting of various 
organic solvents and the stationary phase is polar. The silanol groups on the surface of 
the silica give it a polar character. 
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   In Reverse phase chromatography a wide variety of columns is available 
covering a wide range of polarity by cross linking the silanol groups with alkyl chains 
like C6, C8, C18 and Nitrile groups (-CN), Phenyl groups (-C6H6) and amino groups  (-
NH2). 
ORDER OF THE SILICA BASED COLUMNS 
I--------Non Polar--------Moderately Polar--------Polar--------I 
C18  <  C8  <  C6  <  Phenyl  <  Amino  <  Cyano  <  Silica 
          Experiments are conducted using different columns with different mobile 
phase to achieve best separation. A column which separates all the impurities and 
degradants from API peak and which is rugged with mobile phase variation is 
selected. 
Selection of Solvent Delivery Systems: 
       Chromatographic separations with single eluent i.e., all the constituents of 
mobile phase is mixed and pumped as single eluent is called Isocratic Elution and is 
always preferable. However Gradient Elution is a powerful tool in achieving 
separation between closely eluting compounds having different polarities. The 
importance of Gradient Elution is that the polarity and Ionic strength of the mobile 
phase can be changed during the run. Gradient elution is of two types 
1. Low pressure Gradient and  
2. High pressure Gradient Elution 
          Low pressure Gradient is one in which mobile phases are mixed at pre 
determined ratios and in High pressure Gradient mobile phase are pumped at different 
flow rates to achieve the required composition and mixed in mixing chamber and then 
introduced to the column. Low pressure Gradient is opted when NMT 80% of organic 
phase has to be pumped. High pressure Gradient is opted when more than 80% of 
Chapter 1                                                                                                       Introduction 
Rvs College Of Pharmaceutical Sciences, Coimbatore  Page 29 
   
organic phase has to be pumped. While optimizing the gradient elution it is important 
to monitor the following- 
¾ The graph is to be monitored so as to ensure that the overall system pressure will 
not cross 300 bars at any point during the run. 
¾ Flow rate is to be physically cross checked by collecting the output from the 
detector during the run at different time intervals. This avoids pumping problems 
which may arise due to higher organic phase compositions.  
Selection of Flow Rate: 
Flow rate is selected based on the following factors 
¾ Retention time 
¾ Column composition 
¾ Separation impurities 
¾ Peak symmetry 
  Preferably flow rate shall not be more than 2.5 mL/Min. A flow rate that gives 
least retention times, good peak symmetries, least back pressure and better separation 
of impurities from API peak shall be selected. 
Selection of Column Temperature: 
    Ambient temperature is always preferred as column temperature. However if 
the peak symmetry could not be achieved then the column temperature can be varied 
between 30° to 80°C. If a column temperature above 80°C is found necessary, 
packing material which can withstand to that temperature shall be chosen. The 
increase in column temperature generally will result in reduction in peak asymmetry 
and peak retentions. 
For developing a method, the type of column being used and functionality, structure, 
pKa and reactivity must be considered. Optimize the temperature and adjust the 
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mobile phase compositions to achieve best separation. Usually the silica column 
temperatures stable up to 60°C, optimized flow rate achieve the shortest analysis and 
adequate resolution and efficiency. In Isocratic method performs the analysis at 50°c. 
Reduce the amount of organic modifier in the mobile phase is necessary to produce 
the good separation.   Some column pre heaters are used to preheat the mobile phase 
to avoid broad broadening. Also use peltier chip for precise temperature and controls 
the column effluent. Silica based stationary phases stable at up to 60°c some instances 
up to 90°c.the higher temperature will leads the shorter column life time. At elevated 
temperature the solute transfer from mobile phase to the stationary phase is more 
efficient.  
Selection of Diluent and Extraction Procedure: 
       Diluent for test preparation is selected initially based on solubility of the drug 
substance. It is selected in such a way that the drug substance is soluble in which the 
extraction is complete, due to which there won’t be any interference and in which 
peak symmetry and resolution between impurities and API Peak is found satisfactory. 
General methods followed for extraction are Sonication, Rotatary shaking or both. In 
some cases where API is not extracted by above methods then heating is adopted if 
substance is stable and it should not precipitate upon cooling to room temperature. 
 Experiments are conducted to optimize the extraction of API in the presence 
of excipients at different test concentrations using the diluents chosen based on 
solubility at different time intervals of sonication time or rotary shaking or both and 
select the test concentrations at which the extraction is most efficient. 
          The solubility of Codeine phosphate, Chlorpheniramine maleate and Sodium 
benzoate was determined in a variety of solvents. As per Indian Pharmacopoeial 
standards solubility test for these drugs are carried out in different polar and non-polar 
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solvents. From the solubility studies water was chosen as solvent for the present 
drugs.  
Selection of test concentration and injection volume: 
     The test concentration is generally chosen based upon the response of API 
peak at the selected detector wavelength. However test concentration is finalized after 
it is proved that API is completely extractable at the selected test concentration. 
Generally an injection volume of 10 to 20µL is recommended for estimation of API. 
However if the extractions are found to be difficult then the test concentration can be 
kept low and the injection volume can be increased up to 50µL. But it is to be ensured 
that at the selected volume the column is not overloaded. 
Establishment of Stability of the Solutions: 
   The assessment of stability of the solution is carried out by keeping the test 
solution at Room Temperature and at 2o to 8oC and this test solution is injected along 
with the freshly prepared standard and %RSD of the standard solution and test 
solution is calculated. An acceptance criterion here is that the %RSD should not be 
NMT 2%. 
Establishment of System Suitability: 
     System suitability parameter has to be selected based on the Tailing factor, 
Plate count, Resolution, and RSD. In general resolution factor for the closely eluting 
compounds is selected as a system suitability requirement. If the separation of 
impurities from each other and from API peak is found to be satisfactory, there is no 
need to keep a resolution factor as system suitability parameter. In such cases only 
standard reproducibility and symmetry of standard peak can be adopted as a system 
suitability requirement. 
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1.5 METHOD VALIDATION 15 : 
Validation by definition is an act of proving that any procedures, process, 
equipment, materials, activity or system performs as expected under a given set of 
conditions. Basically validation is proving that the performance is as intended when 
extended to an analytical procedure, depending upon the application, it means that a 
method works reproducibly, when carried out by some different persons, in same or 
different laboratories using different reagents, different equipments etc. 
According to U. S. FDA defines the term “Validation is a process of 
establishing documented evidence which provides a high degree of assurance that a 
specific process will consistently produce meeting, its predetermined specifications 
and quality attributes”. 
According to USP, “Validation of an analytical method is the process by 
which it is established by laboratory studies that the performance characteristic of the 
method meets the requirements for the intended in analytical applications”. 
Purpose of Validation: 
1. Enable the scientists to communicate scientifically and effectively on 
technical matter. 
2. Setting the standards of evaluation procedures for checking compliance and 
taking remedial action. 
3. Economic: Reduction in cost associated with process sampling and testing. 
4. As quality of the product cannot always be assured by routine quality control 
because of testing of statistically insignificant number of samples. 
Types of Analytical Procedures to be validated:  
The discussion of the validation of analytical procedures is directed to the four 
most common types of analytical procedures:- 
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• Identification tests;  
• Quantitative tests for impurities' content;  
• Limit tests for the control of impurities;  
• Quantitative tests of the active moiety in samples of drug substance or 
drug product or other selected component(s) in the drug product. 
Although there are many other analytical procedures, such as dissolution testing for 
drug products or particle size determination for drug substance, these have not been 
addressed in the initial text on validation of analytical procedures. Validation of these 
additional analytical procedures are equally important to those listed herein and may 
be addressed in subsequent documents.  
A brief description of the types of tests considered in this document is 
provided below.  
1. Identification tests are intended to ensure the identity of an analyte in a 
sample. This is normally achieved by comparison of a property of the sample 
(e.g., spectrum, chromatographic behavior, chemical reactivity, etc) to that of 
a reference standard.  
2. Assay procedures are intended to measure the analyte present in a given 
sample. In the context of this document, the assay represents a quantitative 
measurement of the major component(s) in the drug substance. For the drug 
product, similar validation characteristics also apply when assaying for the 
active or other selected component(s). The same validation characteristics may 
also apply to assays associated with other analytical procedures (e.g., 
dissolution).  
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Typical validation characteristics which should be considered are listed below:  
o Accuracy  
o Precision  
o Repeatability  
o Intermediate Precision  
o Specificity  
o Detection Limit  
o Quantitation Limit  
o Linearity  
o Range  
Furthermore revalidation may be necessary in the following circumstances:  
• Changes in the synthesis of the drug substance 
• Changes in the composition of the finished product 
• Changes in the analytical procedure 
The degree of revalidation required depends on the nature of the changes. Certain 
other changes may require validation as well.  
 
 
 
 
 
 
 
Fig. No. 2: Figure showing Validation parameters. 
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ACCURACY:  
                     It is the closeness of agreement between the actual value of the drug and 
the measured value. Spike and recovery Studies are performed to measure accuracy, a 
known sample is added to the excipients and the actual drug value is compared to the 
value found by the assay. Accuracy is expressed as the bias or the % error between 
the observed value and the true value (assay value/actual value x 100%).  
PRECISION: 
The precision of an analytical procedure expresses the closeness of agreement 
(degree of scatter) between a series of measurements obtained from multiple sampling 
of the same homogeneous sample under the prescribed conditions. Precision may be 
considered at three levels: repeatability, intermediate precision and reproducibility.  
Precision should be investigated using homogeneous, authentic samples. However, if 
it is not possible to obtain a homogeneous sample it may be investigated using 
artificially prepared samples or a sample solution.  
The precision of an analytical procedure is usually expressed as the variance, standard 
deviation or coefficient of variation of a series of measurements. 
REPEATABILITY: 
Repeatability expresses the precision under the same operating conditions over a short 
interval of time. Repeatability is also termed intra-assay precision.  
INTERMEDIATE PRECISION: 
Intermediate precision expresses within-laboratories variations; different days, 
different analysts, different equipment, etc.  
REPRODUCIBILITY:  
Reproducibility expresses the precision between laboratories (collaborative studies, 
usually applied to standardization of methodology).  
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It is expressed as the coefficient of variation (% CV). CV is the standard deviation of 
the assay values divided by the concentration of the analyte. Several types of 
precision can be measured: intra-assay precision (repeatability) is the % CV of 
multiple determinations of a single sample in a single test run; inter-assay precision 
(also called intermediate precision) measures the % CV for multiple determinations of 
a single sample, controls and reagents analyzed in several assay runs in the same 
laboratory.  
LINEARITY: 
A linearity study verifies that the sample solutions are in concentrations range 
where analyte response is generally performed by preparing standard solutions at five 
concentration levels from 50 to 150% of the target analyte concentrations five levels 
are required to allow detection of curvature in the plotted data. 
Validation over a wide range provides confidence that the routine range 
provides confidence that the routine standard levels are well removed from non linear 
response concentrations that the method covers a wide enough range to incorporate 
the limits of content uniformity testing. 
Acceptance of linear data is often judged by examining the correlation 
coefficient >0.999 is generally considered as evidence of acceptable fit of the data. 
For the evaluation of linearity five different concentrations of standard   solutions 
were prepared. The concentration ranges that prepared were between 25 to 125 μg/ml 
for. A graph is plotted to “area” versus amount found”. The co-relation coefficient 
was found to be 0.999. It is the ability of an assay to obtain test results, which are 
directly proportional to the concentration of an analyte in the sample. The 
determination of this parameter will identify the range of the analytical assay. It can 
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be measured as slope of the regression line and its variance or as the coefficient of 
determination and correlation coefficient (R). 
RANGE: 
            The range of an analytical method is the interval between the upper and lower 
levels (including these levels) that have been demonstrated to be determined with 
precision, accuracy and linearity using the method as written. The range is normally 
expressed in the same units as the test results (e.g., percentage, parts per million) 
obtained by the analytical method. 
SPECIFICITY: 
Specificity is the ability to assess unequivocally the analyte in the presence of 
components which may be expected to be present. Typically these might include 
impurities, degradants, matrix, etc. Lack of specificity of an individual analytical 
procedure may be compensated by other supporting analytical procedure(s).  
This definition has the following implications:  
Identification: to ensure the identity of an analyte.  
Purity Tests: to ensure that all the analytical procedures performed allow an accurate 
statement of the content of impurities of an analyte, i.e. related substances test, heavy 
metals, residual solvents content, etc.  
Assay (content or potency): To provide an exact result which allows an accurate 
statement on the content or potency of the analyte in a sample.  
LIMIT OF DETECTION (LOD):  
            It is the lowest amount of the analyte in a sample that can be detected but not 
necessarily be quantitated as an exact concentration or amount. The detection limit of 
an individual analytical procedure is the lowest amount of an analyte in the sample 
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that can be detected but not necessarily quantitated as an exact value. The Limit of 
LOD value is 3. 
 For determining LOD initially standard deviation and slope of calibration curve was 
calculated.          
 
 
 Where,S1 = slope of calibration curve    
           SD = standard deviation of peak response 
             S = signal obtained from the LOD solution. 
            N = average base line noise.                                                                                                         
LIMIT OF QUANTITATION (LOQ):  
It is the lowest amount of an analyte that can be measured quantitatively in a 
sample with acceptable accuracy and precision. The LOQ is a parameter for tests 
measuring impurities in a drug product. 
The quantification limit of an individual procedure is the lowest amount of 
analyte in the sample that can be quantitatively determined with suitable precision and 
accuracy.  The limit of LOQ value is 10. 
For determining LOQ initially standard deviation and slope of calibration 
curve was calculated.   
  LOQ =  10 (SD/S) 
                 Or 
                   LOQ = S/N 
 
 
 
LOD  = 3.3 SD/S1 
LOD  = S/N 
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ROBUSTNESS: 
             It is the capacity of an assay to remain unaffected by deliberate changes to 
various parameters of the method and gives an indication of its reliability during 
normal assay conditions. The variations could be in room or incubator temperature or 
humidity, variations in incubation times, minor variations in pH of a reagent, etc. 
      SYSTEM SUIITABILITY: 
Tailing factor for the peaks due to Codeine phosphate, Chlorpheniramine 
maleate and Sodium benzoate Standard solution should not be more than 1.5. 
Theoretical plates for the peaks in Codeine phosphate, Chlorpheniramine maleate and 
Sodium benzoate Standard solution should not be less than 2500. 
      ASSAY: 
             
 
 
Where:   
 AT = Peak Area of Standard solution. 
 AS = Peak Area of test solution. 
 WS = Weight of working standard taken in mg 
 WT = Weight of sample taken in mg  
 DS = Dilution of Standard solution  
 DT = Dilution of sample solution 
          P   = Percentage purity of working standard 
 
>The limit of assay is in between the 98% - 102%. 
         AT                  WS           DT           P             Wt/ml 
 ------------- x ----------x --------- x ----------x------------------ X 100 
       AS              DS           WT         100           Label Claim 
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2.1 DRUG PROFILE 
COUGH SYRUP FORMULATION 
 
Description: It is orange red coloured flavor based syrup.  
Category: Antitussive. 
Composition: 
Each 5ml syrup contains:  
(a) Codeine phosphate             ---------10mg                                     
(b) Chlorpheniramine Maleate --------- 4mg                                         
(c) Sodium Benzoate               --------- 10mg 
The general formulations known as cough medicines contain several 
active ingredients. They are usually a combination of an antitussive, 
antihistaminic drug.  
The pure drugs are obtained from in-house for analysis.  
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2.1.1 CODEINE PHOSPHATE 16 
Molecular structure: 
 
Molecular formula:  C 18H 21NO 3H 3PO41/2H 20. 
Chemical name: 7, 8-Didehydro-4, 5alpha-epoxy-3-methoxy-17-
methylmorphinan-6alpha-ol phosphate (1:1) (salt) hemihydrates. 
Molecular weight: 406.4 
CAS No: 76-57-3 
 Physical appearance: white crystalline powder, odorless and bitter in 
taste. 
Solubility: soluble in water. 
pKa: 8.21 
Category:  Antitussive & Analgesic. 
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 2.1.2 CHLORPHENIRAMINE MALEATE 17 
Molecular structure: 
 
                                      Chlorpheniramine Maleate 
Molecular formula: C20 H23ClNO4 
Chemical name: [3-(4-chlorophenyl)-3-(pyridin-2-yl)propyl] 
dimethylamine. 
Molecular weight: 390.86 
CAS No: 132-22-9 
Physical appearance: Odorless white crystalline solid or white powder 
with a bitter taste. 
Solubility: soluble in water. 
pKa: 4.21 
Category:  Antipruritic, Anti-Allergic Agent, Histamine (H1)Antagonist.         
 
 
 
 
 
 
Chapter 2                                                                                                     Drug Profile 
Rvs College Of Pharmaceutical Sciences, Coimbatore  Page 43 
 
2.1.3 SODIUM BENZOATE 18 
Molecular structure: 
 
                                          Sodium Benzoate 
Molecular formula:  C6H5COONa (C7H5NaO2) 
Molecular weight: 144.12 
CAS No: 532-32-1 
Appearance: White, odorless granules, pellets, or powder 
Solubility: in water and in ethanol. 
pKa: 8.0 
Category: Preservative and pH stabilizer. 
 
 
 
 
 
 
 
 
Chapter 2                                                                                                     Drug Profile 
Rvs College Of Pharmaceutical Sciences, Coimbatore  Page 44 
 
2.2 LITERATURE REVIEW: 
1. Fuad Al-Rimawi et al., (2010) 19 developed and validated Normal-
phase LC method for simultaneous analysis of Pseudoephedrine 
hydrochloride, Dextromethorphan hydrobromide, 
Chlorpheniramine maleate and Paracetamol in tablet formulations 
and Separation was achieved on a silica column (5 μm, 
125 × 4.6 mm inner diameter) using a mobile phase consisting of 
methanol/ammonium dihydrogen phosphate buffer (90:10, v/v) at a 
flow rate of 1.0 ml/min and UV detection at 220 nm. This new 
method is validated in accordance with USP requirements for new 
methods for assay determination, which include accuracy, 
precision, selectivity, linearity and range, robustness and 
ruggedness. 
2. Mukesh Maithani et al., (2010) 20 developed reverse phase high 
performance liquid chromatographic method for the simultaneous 
determination of chlorpheniramine maleate and phenylephrine in 
tablet dosage forms. A reversed-phase C-18 column (250 mm × 8 
mm i.d., particle size 10 µm) column with mobile phase consisting 
of acetonitrile and phosphate buffer 55:45 (v/v) (pH 5.6 ± 0.02, 
adjusted with triethylamine) was used. The flow rate was 1.0 ml/ 
min and effluents were monitored at 255 nm. The retention times 
of chlorpheniramine maleate and phenylephrine were found to be 
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3.13 min and 4.58 min, respectively. The method was validated in 
terms of linearity, range, specificity, accuracy, precision, limit of 
detection (LOD) and limit of quantitation (LOQ). 
3. Adnan Manassra et al., (2009) 21 proposed an HPLC method using 
UV detection for the simultaneous determination of 
pseudoephedrine hydrochloride, codeine phosphate and triprolidine 
hydrochloride in liquid formulation. C18 column 
(250 mm × 4.0 mm) is used as the stationary phase with a mixture 
of methanol: acetate buffer: acetonitrile (85:5:10, v/v) as the 
mobile phase. The factors affecting column separation of the 
analytes were studied. The calibration graphs exhibited a linear 
concentration range of 0.06–1.0 mg/ml for pseudoephedrine 
hydrochloride, 0.02–1.0 mg/ml for codeine phosphate, and 0.0025–
1.0 mg/ml for triprolidine hydrochloride for a sample size of 5 μl 
with correlation coefficients of better than 0.999 for all active 
ingredients studied. The results demonstrate that this method is 
reliable, reproducible and suitable for routine use. 
4. Ezzat M. Abdel-Moety et al., (2009) 22 developed a selective and 
stability-indicating RP HPLC method for the simultaneous precise 
determination of promethazine and sodium benzoate even in the 
presence of main oxidative degradation products of promethazine. 
Good separation can be achieved on a C-18 column by using 
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mobile phase composed of 0.008m ammonium acetate and 
methanol (52:48v/v) by adopting isocratic elution programmed 
with UV detection at 253 nm. The method was linear over the 
concentration ranges of 4-60 µ ml-1 & 0.2-3 mg ml-1, with accuracy 
of 100.68 ± 1.49% and 101.82 ±0.91% and limits of quantitation 
(LOQ) of 0.8 µg/ ml-1 & 20µg/ml for promethazine and sodium 
benzoate in orders.  
5. Aravindaraj Joghee Rajua et al., (2007) 23 developed and validated 
a convenient liquid chromatographic-single Quadrupole mass 
spectrometric (LC-MS) method for dexchlorpheniramine maleate 
(INN name: chlorpheniramine) determination in human plasma. 
The linearity was also excellent over the range of 1 to 150ng/ml of 
dexchlorpheniramine maleate concentration. The method was 
statistically validated for its selectivity, linearity, precision and 
robustness. This method was successfully applied to the analysis of 
chlorpheniramine maleate in clinical studies. 
6. Maria-Elisa Capella-Peiro et al., (2006) 24 optimized Capillary zone 
electrophoresis method to quantitatively determine codeine and 
paracetamol via central composite factorial design. Optimum 
separation conditions were achieved using phosphate buffer 
20 mM (pH 6.8) and voltage (15 kV). The optimized procedure 
easily determined codeine and paracetamol with separation in less 
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than 3 min. Calibration curves (R > 0.999) were prepared, with 
LODs of 13.5 and 340 ng mL−1 for codeine and paracetamol, 
respectively, and a good R.S.D% (<3%). This method was applied 
to determine codeine and paracetamol in pharmaceutical 
formulations; recoveries coincided with stated contents. 
7. María R. Gomez et al., (2005) 25 described a simple, accurate and 
rapid method for the separation and simultaneous determination of 
codeine, diphenhydramine, ephedrine and noscapine present in 
cough–cold syrup formulations by capillary zone electrophoresis. 
Separations were carried out in less than 10 min with a 20 mM 
sodium tetraborate buffer, pH 8.50. The carrier electrolyte gave 
baseline separation with good resolution, great reproducibility and 
accuracy. 
8. V. Galli et al., (2004) 26 proposed a High-performance liquid 
chromatographic analysis of dextromethorphan, guaifenesin and 
benzoate in a cough syrup for stability testing. Forced degradation 
was also studied to demonstrate that the method could be employed 
during a stability study of the syrup. Final conditions were 
phosphate buffer (25 mM, pH 2.8) with triethylamine (TEA): 
acetonitrile (75:25, v/v). In such conditions, all the actives, 
excipients and degradation products were baseline resolved in less 
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than 14 min, and different wavelengths were used for the different 
analytes and related compounds. 
9. Mohsen Kompany-Zareh et al., (2004) 27 carried out 
spectrophotometric resolution of ternary mixtures of 
pseudoephedrine hydrochloride, dextromethorphan hydrobromide 
and sodium benzoate in syrups using wavelength selection by net 
analyte signals calculated with hybrid linear analysis (HLA). HLA 
was applied because it was simpler to adapt to the NAS regression 
plot methodology, and also used less factors than partial 
determinations. The method was successfully applied for the 
determination of pseudoephedrine HCl, dextromethorphan HBr, 
and sodium benzoate in cough suppressant syrup samples. 
10. A Garcia et al., (2003) 28 utilized Polyethylene glycol column for 
the determination of acetaminophen, phenylephrine and 
chlorpheniramine in pharmaceutical formulations with Supelco 
Discovery HS PEG column poly (ethylene glycol) 15×0.46 cm, 5 
μm. The mobile phase was 20 mM phosphate buffer, pH 7.0–
acetonitrile (90:10, v/v) at a flow-rate of 1 ml/min. UV detection 
was performed at 215 nm for all the compounds except 
acetaminophen, which was measured at 310 nm. Validation 
parameters permit us to consider this method suitable. 
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11. Darryl J. Hood et al., (2002) 29 developed a simple, accurate and 
precise reversed phase HPLC method for rapid and simultaneous 
quantification of codeine phosphate, ephedrine HCl and 
Chlorpheniramine maleate in a cough–cold syrup formulation. 
Separations were carried out on a Zorbax® XDB C8 column 
(150×4.6 mm ID), 5 μm particle size. A gradient elution system 
was developed using varying percentages of two mobile phases: 
methanol: glacial acetic acid: triethylamine (980:15:6 v/v) and 
water–glacial acetic acid–triethylamine (980:15:6 v/v) with run 
time in less than 7 min with a flow rate of 1.5 ml/min and detected 
at a wavelength of 254 nm. The method was validated and met all 
analysis requirements of quality assurance and quality control 
recommended by FDA of the USA. 
12. A.Marín et al., (2002) 30 proposed the Validation of a HPLC 
quantification of acetaminophen, phenylephrine and 
chlorpheniramine in pharmaceutical formulations: capsules and 
sachets. Final chromatographic conditions were a gradient elution, 
being solvent A: phosphate buffer 40 mM at pH 6.0 and solvent B: 
acetonitrile. UV detection was performed at 215 nm for 
phenylephrine and chlorpheniramine, because at this wavelength 
sensitivity was higher than in other more characteristic 
wavelengths and it were necessary for the detection of minor 
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compounds. For acetaminophen 280 nm was employed. Validation 
parameters permit to consider the method adequate. 
13. Murat Kartal et al., (2001) 31 proposed LC method for the analysis 
of paracetamol, caffeine and codeine phosphate in pharmaceutical 
preparations. Paracetamol, caffeine and codeine phosphate were 
separated using a μBondapack C8 column by isocratic elution with 
flow rate 1.0 ml/min. The mobile phase composition was 
420/20/30/30 (v/v/v/v) 0.01M KH2PO4, methanol, acetonitrile, 
isopropyl alcohol and spectrophotometric detection was carried out 
at 215 nm. The linear range of detection for paracetamol, caffeine 
and codeine phosphate was between 0.400 and 1500 μg/ml; 0.075 
and 90 μg/ml; 0.300 and 30 μg/ml respectively. The method has 
been shown to be linear, reproducible, specific, sensitive and 
rugged. 
14. Ruby Ragonese et al., (2000) 32 described the testing of a saturated 
factorial design using a full factorial design. Saturated factorial 
designs are often used to test the robustness of high-performance 
liquid chromatography (HPLC) methods. A full factorial design 
relies on fewer assumptions and hence could be used to evaluate 
the effectiveness of the saturated design. Both designs were used to 
test a gradient HPLC method for the assay of codeine phosphate, 
pseudoephedrine hydrochloride and Chlorpheniramine maleate. Six 
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HPLC conditions, including wavelength, mobile phase pH and ion 
pairing reagent concentration were tested using the saturated 
design. One interaction effect was indicated as a confounding 
effect by the saturated design and this was confirmed by the 
calculation of the same interaction effect using the full design. 
Overall the method was shown to be robust under the variety of 
HPLC conditions tested. 
15. Io-Wah Lau et al., (1995) 33 proposed an HPLC method using 
indirect conductometric detection for the simultaneous 
determination of eight active ingredients in cough-cold syrups. It 
involves the use of an Ultrasphere 5 μm Spherical 80 Å Pore CN 
analytical column (250 mm × 4.6 mm) as the stationary phase with 
a mixture of water, acetonitrile and ethanol (38:60:2) containing 1 
mM perchloric acid as the mobile phase. The active ingredients 
included bromhexine hydrochloride, chlorpheniramine maleate, 
codeine phosphate, dextromethorphan hydrobromide, 
diphenhydramine hydrochloride, ephedrine hydrochloride, 
papaverine hydrochloride and phenylephrine hydrochloride. 
16. Brianne Weingarten et al., (1995) 34 developed a rapid, reliable and 
rugged assay for determining codeine in human plasma using 
reversed-phase high-performance liquid chromatography with 
fluorescence detection. This analytical method utilized an ion-
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exchange/mixed-mode solid-phase extraction procedure. The 
chromatographic separation was achieved using a 150 × 4.6 mm 
I.D., 3-μm reversed-phase C8 (deactivated for basic analytes) 
column at ambient temperature. Fluorescence detection (excitation 
at 214 nm and emission above 345 nm) for codeine and nalorphine 
allowed for a detectable limit of 5 ng/ml. The results showed that 
the method was linear from 10 to 300 ng/ml. The method had good 
reproducibility, precision, accuracy and recoveries of 91 and 90% 
for codeine and nalorphine, respectively. This method has been 
applied to study the pharmacokinetics of codeine in normal human 
subjects. 
17. G. Santoni et al., (1992) 35 developed a reversed-phase high-
performance liquid chromatographic method for the simultaneous 
determination of aspirin, propyphenazone and codeine phosphate 
in an analgesic tablet formulation. The proposed method is also 
suitable for the determination of small quantities of salicylic acid. 
The elution was isocratic using two C-8 columns and methanol-
water (45:55) as mobile phase with 1.4% acetic acid and 5 mM 
tetramethylammonium bromide. 
18. Zhao Rong Chen et al., (1989) 36 developed a novel high-
performance liquid chromatographic method for the determination 
of codeine, norcodeine and morphine in plasma and urine. The 
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compounds were separated on a cyano column (15 cm×4.6 mm, 5 
μm particle size) using a mobile phase of acetonitrile-
triethylamine-distilled water (4:0.1:95.9, v/v) pH 3.1 and then 
determined by fluorescence detection. Calibration curves in the 
range 5–200 ng/ml for plasma and 0.1–10 μg/ml for urine were 
linear and passed through the origin. The imprecision and 
inaccuracy of the assay were less than 10% and the limits of 
detection were 2 ng/ml for all three compounds in human plasma. 
19. O.W.Lau et al., (1989) 37 proposed a simple, rapid and accurate 
method for the simultaneous determination of active ingredients in 
cough—cold mixtures using isocratic ion-pair RP-HPLC method 
with an octadecylsilane column as the stationary phase and 
methanol, water, tetrahydrofuran, phosphoric acid mixtures as 
mobile phase including sodium dioctylsulphosuccinate as the ion-
pair agent. The pH of the mobile phase was adjusted to 4.6 by 
means of phosphoric acid and ammonium hydroxide solutions. The 
proposed method involves the simple dilution of the samples with 
the mobile phase and the addition of metoclopramide 
hydrochloride as the internal standard.  
20. Ron Ginman et al., (1985) 38 described a procedure for the 
simultaneous determination of codeine and ibuprofen in human 
plasma following the administration of the two substances in a 
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proposed combination dosage form. The two substances were 
extracted separately from plasma and then determined together by 
high-performance liquid chromatography (HPLC) using a 
fluorescence detector. The codeine was first extracted from 
alkalinized plasma with hexane: dichloromethane (2:1, v/v) and 
then washed with sodium hydroxide solution. The ibuprofen was 
then extracted with hexane from the plasma acidified with 
sulphuric acid. The organic layers were collected, evaporated to 
dryness and the reconstituted residue was subjected to HPLC. The 
detection limit for codeine was 8 μg 1−1 and for ibuprofen 1 mg 1−1. 
From the literature review, there is no proposed method for the 
quantification of these three compounds, namely codeine phosphate, 
chlorpheniramine maleate and sodium benzoate in combination in a syrup 
formulation.  
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2.3 AIM AND OBJECTIVE 
 The literature review reveals that numerous works have been carried out on 
RP-HPLC, capillary zone electrophoresis, spectrophotometric methods for the 
quantification of Codeine phosphate, Chlorpheniramine maleate and Sodium benzoate 
either individually or in combination with other drugs. The combination of Codeine 
phosphate, Chlorpheniramine maleate active drugs and Sodium benzoate as 
preservative is used in pharmaceutical preparations as cough syrup. This formulation 
is marketed by M/s Vivimed labs ltd, Hyderabad as a cough syrup. Codeine phosphate 
acts as antitussive, Chlorpheniramine maleate acts as antihistaminic and Sodium 
benzoate acts as preservative and pH stabilizer in the formulation. The need for 
determination of Sodium benzoate in the present study is that it is physically and 
chemically compatible for syrup formulation which improves shelf life of product. In 
this respect, a method for the analysis of this combination is needed for simultaneous 
quantification of all three combined components in one step.  
  The present study describes the development of a new rapid, efficient and 
reproducible RP-HPLC method using gradient mobile phase for the analysis of Codeine 
phosphate, Chlorpheniramine maleate and Sodium benzoate preservative in 
combination in cough syrup that offers certain advantages in its simplicity and time 
saving and applicable in routine analysis. It also describes the development of 
validation work as per ICH Q2B guidelines recommended by the Food and Drug 
Administration (FDA) of the United States. 
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2.4 PLAN OF WORK 
                        Aimed to develop analytical method development and validation for Codeine 
phosphate, Chlorpheniramine maleate and Sodium benzoate in combination in a cough syrup 
formulation. 
The plan of the proposed work includes the following steps: 
• The extensive survey of literature for Codeine phosphate, Chlorpheniramine maleate and 
Sodium benzoate regarding their physico-chemical properties and analytical methods. 
This forms the basis for the development of methods. 
• To undertake solubility studies for the analytes codeine phosphate, chlorpheniramine 
maleate and sodium benzoate. 
• Selection of suitable solvent for quantitative extraction of analyte present in the 
formulations. The solvent should be readily available, economical and of analytical 
grade. 
• To develop initial chromatographic conditions by selection of suitable column and 
appropriate wavelength in UV for detection and optimization of the method. 
• To validate analytical method developed as per the ICH Q2B guidelines.  
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 3. EXPERIMENTAL DETAILS 
 
3.1 MATERIALS AND METHODS: 
List of chemicals used: 
Table No 3: Table showing list of the chemicals used. 
 
S.No Chemical name Supplier’s Name Grade 
 
1. Codeine phosphate 
Vivimed labs ltd, 
Hyderabad, India. 
In house Working 
standard 
 
2. 
Chlorpheniramine maleate 
Vivimed labs ltd, 
Hyderabad, India. 
In house Working 
standard 
 
3. Sodium benzoate 
Vivimed labs ltd, 
Hyderabad, India. 
In house Working 
standard 
 
4. 
Diammonium hydrogen 
orthophosphate 
S.D.fine chemicals 
limited, Mumbai, 
India. 
 
LR 
 
5. Ortho phosphoric acid 
Merck, Mumbai, 
India. 
AR 
 
6. 
Lichrosolv HPLC grade 
water 
Merck, Mumbai, 
India. 
AR 
 
7. 
Acetonitrile 
Merck, Mumbai, 
India. 
AR(HPLC grade) 
 
8. Methanol 
Merck, Mumbai, 
India. 
AR(HPLC grade) 
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List of instruments used: 
Table No 4: Table showing list of the instruments used. 
S.No Instruments Model Manufacturer Software 
1. HPLC Model 2695 Waters Empower2 
2. 
HPLC-U.V 
detector 
Model 2489 
Waters Dual λ 
absorbance detector 
Nil 
3. Analytical balance ------------ Mettler Toledo Nil 
4. 
Ultrasonicate water 
bath 
----------- 
Ultrasonicate SE-
COUS 
Nil 
5. pH meter LI 127 
Elico, Hydrogen 
Electrode 
Nil 
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3.2 METHOD DEVELOPMENT- 
SELECTION OF DETECTOR WAVE LENGTH:  
The wave length selection is made at 254 nm since all the three compounds maximum 
absorbance in UV spectrum as reported in the literature is in between 254-258 nm.  
TRIAL&ERROR METHODS:  
TRIAL -1: 
CHROMATOGRAPHIC CONDITIONS: 
Column                    : Spherisorb C18 250×4.6mm, 5µm. 
Detector                   : 254nm 
Flow rate                 : 1.2ml/min 
Injection volume     : 50µl 
Run time                 : 20min 
Mobile Phase          : Buffer (pH: 3.5): Acetonitrile: Methanol (40:40:20) 
Chromatogram of trial no: 1 is as shown in Fig No: 2. 
TRIAL- 2: 
CHROMATOGRAPHIC CONDITIONS: 
Column                         : Spherisorb C18, 150×4.6mm, 5µm. 
Detector                        : 254nm 
Flow rate                      : 1.2ml/min 
Injection volume          : 50µl 
Run time                      : 20min 
Mobile phase               : Buffer (pH-3.0): Acetonitrile (50:50)  
Chromatogram of trial no: 2 is as shown in Fig. No: 3. 
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Trail-3: Final method 
CHROMATOGRAPHIC CONDITIONS: 
Column                         : ZODIAC C18 150×4.6mm, 3.5µm. 
Detector                        : 254nm 
Flow rate                       : 1.5ml/min 
Injection volume            : 50µl 
Run time                        : 25min 
Column temperature      : 30°c 
Program                         : gradient           
Gradient program 
Time (Minutes) Solvent-A (%) Solvent-B (%) 
0.01 95 5 
5 90 10 
10 60 40 
15 60 40 
20 95 5 
25 95 5 
 
              Chromatogram of trial no: 3 final methods are as shown in Fig. No: 4. 
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ANALYTICAL METHOD-OPTIMISATION 
Aim: The present study is to develop a new reverse phase liquid chromatographic 
method for simultaneous determination of codeine phosphate, chlorpheniramine 
maleate, sodium benzoate in a syrup formulation.  
Table No. 5: Table showing Optimized Chromatographic Parameters. 
OPTIMIZED CHROMATOGRAPHIC CONDITIONS 
Mode of separation Gradient elution 
Mobile phase Solvent-A: Phosphate buffer pH-2.3 
Solvent-B: Acetonitrile 
Column Zodiac C-18,3.5µ,150×4.6mm 
Flow rate 1.5 mL/ min 
Detection  Wavelength 254 nm 
Injection volume 50 μl 
Column oven temperature Ambient(30°C) 
Run time 25 min 
  
                     Table No.6: Table showing Gradient program of elution. 
Time (Minutes) Solvent-A (%) Solvent-B (%) 
0.01 95 5 
5 90 10 
10 60 40 
15 60 40 
20 95 5 
25 95 5 
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Procedure: 
Preparation of Buffer solution: 
Weighed accurately 3.3gm of Diammonium hydrogen orthophosphate and dissolved 
in 1000 ml of water and adjusted the pH to 2.3 with Orthophosphoric acid. 
Diluent:   HPLC grade water. 
Preparation of Standard Solution: 
Accurately weigh and transfer 50mg of Codeine phosphate, 20mg 
Chlorpheniramine maleate & 50mg of Sodium benzoate working standards into a 100 
ml volumetric flask, add about 70 ml of diluent and sonicate to dissolve it completely 
and  make volume up to the mark with the same solvent . 
Further pipette 5 ml of the above stock solution into a 25ml volumetric flask and 
dilute up to the mark with diluent. Mix well and filter through 0.45µm filter. 
            Inject 50 μl of the standard solution into the chromatographic system and measure the 
area for the Codeine phosphate, Chlorpheniramine maleate and Sodium benzoate 
peaks and calculate the %Assay by using the assay formula.  
            Chromatogram of standard solution is as shown in Fig No: 4 
Assay procedure: 
Preparation of Sample Solution:  
             Accurately pipette out 5ml of the sample (equivalent to 1.264gm/ml) into a 100ml 
volumetric flask and 70ml of diluent was added and mixed well and made up to the 
mark with diluent. Mix well and filter through 0.45µm filter.  
            Inject 50 μl of the sample solution into the chromatographic system and measure the 
area for the Codeine phosphate, Chlorpheniramine maleate and Sodium benzoate 
peaks and calculate the %Assay by using the assay formula.  
Chromatogram of sample solution is as shown in Fig No: 5. 
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Assay formula: 
                    AT               WS           DT           P               Wt/ml 
 --------------- x ----------x --------- x ----------x------------------ X 100 
           AS              DS           WT         100         Label Claim 
Where,   
 AT = Peak Area of sample solution. 
 AS = Peak Area of standard solution. 
 WS = Weight of working standard taken in mg 
 WT = Weight of sample taken in mg  
 DS = Dilution of Standard solution  
 DT = Dilution of sample solution 
          P   = Percentage purity of working standard. 
Acceptance criteria: The limit of assay is in between the 98% - 102%. 
The chromatograms are as shown in Fig. No: 6-8 and assay results are tabulated and 
are as shown in Table No: 8.  
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3.3 METHOD VALIDATION 
Definition: Validation is a process of establishing documented evidence which 
provides a high degree of assurance that a specific process will consistently produce 
meeting, its predetermined specifications and quality attributes. 
The objective of the analytical procedure should be clearly understood since this 
will govern the validation characteristics which need to be evaluated. Typical 
validation characteristics which should be considered are listed below:  
• Accuracy  
• Precision  
• Specificity 
• Detection Limit 
• Quantitation Limit 
• Linearity & Range 
• Robustness 
• Ruggedness 
• System suitability testing 
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Table No: 7 Table showing Validation parameters and Requirements. 
S.No Parameter Requirements 
1. Accuracy %Recovery. 
2. Precision SD, %RSD. 
3. Linearity Correlation coefficient, y-intercept,    
Slope of regression line. 
4. Range 80-120% of test solution. 
5. Specificity No interference to be observed,       
Assay results unaffected. 
6. Robustness %RSD 
7. Ruggedness %RSD 
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3.3.1 SYSTEM SUITABILITY TESTING: 
System suitability testing is an integral part of many analytical procedures. The tests 
are based on the concept that the equipment, electronics, analytical operations and 
samples to be analyzed constitute an integral system that can be evaluated as such. 
System suitability test parameters to be established for a particular procedure depend 
on the type of procedure being validated and the parameters like tailing factor, 
retention time, theoretical plates per unit, resolution factor are determined and the 
results are tabulated and are as shown in Table No: 9. 
3.3.2 ACCURACY: 
The accuracy of an analytical procedure expresses the closeness of agreement 
between the value which is accepted either as a conventional true value or an accepted 
reference value and the value found. This is sometimes termed trueness. Accuracy 
should be reported as percent recovery by the assay of known added amount of 
analyte in the sample or as the difference between the mean and the accepted true 
value together with the confidence intervals. Accuracy may be inferred once 
precision, linearity, and specificity have been established. 
Procedure: 
Preparation of Standard solution (100µg/ml):     
Accurately weigh and transfer 50mg of Codeine phosphate and 20mg of 
Chlorpheniramine maleate and 50mg of Sodium benzoate working standards into a 
100 ml volumetric flask, add about 70 ml of diluent and sonicate to dissolve it 
completely and make volume up to the mark with the same solvent. (Stock solution) 
Further pipette 5 ml of the above stock solution into a 25ml volumetric flask 
and dilute up to the mark with diluent. Mix well and filter through 0.45µm filter.  
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Preparation of 50% sample solution: 
Accurately weigh and transfer 25mg of Codeine phosphate and 10 mg of 
Chlorpheniramine maleate and 25mg of Sodium benzoate into a 100 ml volumetric 
flask, add about 70 ml of diluent and sonicate to dissolve it completely and make 
volume up to the mark with the same solvent. (Stock solution) 
Further pipette 5ml of the above stock solution into a 25ml volumetric flask 
and dilute up to the mark with diluent. Mix well and filter through 0.45µm filter. 
Preparation of 100% solution: 
 Accurately weigh and transfer 50mg of Codeine phosphate and 20mg of 
Chlorpheniramine maleate and 50mg of Sodium benzoate working standards into a 
100 ml volumetric flask, add about 70 ml of diluent and sonicate to dissolve it 
completely and make volume up to the mark with the same solvent. (Stock solution) 
          Further pipette 5 ml of the above stock solution into a 25ml volumetric flask 
and dilute up to the mark with diluent. Mix well and filter through 0.45µm filter. 
 Preparation of 150% solution: 
Accurately weigh and transfer 75 mg of Codeine phosphate and 30 mg of 
Chlorpheniramine maleate and 75mg of Sodium benzoate API sample into a 100 ml 
volumetric flask, add about 70 ml of diluent and sonicate to dissolve it completely and 
make volume up to the mark with the same solvent. (Stock solution) 
Further pipette 5ml of the above stock solution into a 25ml volumetric flask 
and dilute up to the mark with diluent. Mix well and filter through 0.45µm filter. 
Inject 50μl of placebo and standard solutions of Accuracy -50%, Accuracy -100% and 
Accuracy -150% solutions into HPLC. Now calculate the amount obtained and amount 
added (API) for Codeine phosphate and Chlorpheniramine maleate and Sodium 
benzoate samples. Calculate the concentration in μg/ml in the spiked placebo in all the 
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above cases by comparing with the standard solution. Calculate the individual recovery 
and mean recovery values. The chromatograms are as shown in Fig. No: 9-12 and the 
results are tabulated and shown in Table No: 10. 
Formula:                  %recovery     =     (Amount recovered)      × 100 
                                                                (Actual amount added) 
Acceptance criteria: 
Percentage recovery in all the cases should be between 98.0 and 102.0 %. 
3.3.3 PRECISION: 
The precision of an analytical procedure expresses the closeness of agreement (degree 
of scatter) between a series of measurements obtained from multiple sampling of the 
same homogeneous sample under the prescribed conditions. Precision may be 
considered at three levels: repeatability, intermediate precision and reproducibility. 
Precision should be investigated using homogeneous, authentic samples using a 
minimum of 6 determinations at 100 percent of the test concentration. The precision 
of an analytical procedure is usually expressed as the variance, standard deviation or 
coefficient of variation of a series of measurements. 
Repeatability 
Repeatability expresses the precision under the same operating conditions over a short 
interval of time. Repeatability is also termed intra-assay precision.  
Intermediate precision 
Intermediate precision expresses within-laboratories variations: different days, 
different analysts, different equipment etc. 
Reproducibility 
Reproducibility expresses the precision between laboratories (collaborative studies, 
usually applied to standardization of methodology). 
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Procedure: 
A) System Precision: 
Preparation of Standard Solution (100 µg/ml): 
Accurately weigh and transfer 50mg of Codeine phosphate and 20mg of 
Chlorpheniramine maleate and 50mg of Sodium benzoate working standards into a 
100 ml volumetric flask, add about 70 ml of diluent and sonicate to dissolve it 
completely and make volume up to the mark with the same solvent. (Stock solution) 
          Further pipette 5 ml of the above stock solution into a 25ml volumetric flask 
and dilute up to the mark with diluent. Mix well and filter through 0.45µm filter.  
          Inject 50µl of the blank solution and the standard solution of 100 µg/ml for six 
times and calculate the %RSD for the area of six replicate injections. The chromatograms 
are as shown in Fig No: 13-19 and the results are tabulated shown in Table No: 11. 
B) Method Precision: 
Preparation of Sample Solution:  
             Accurately pipette out 5ml of the sample (equivalent to 1.264gm/ml) into a 100ml 
volumetric flask and 70ml of diluent was added and mixed well and made up to the 
mark with diluent. Mix well and filter through 0.45µm filter.  
          Inject 50µl of the blank solution and six replicate injections of sample solution of 
100 µg/ml for six times and calculate the %RSD for the area of six replicate injections. 
The chromatograms are as shown in Fig No: 20 and the results are tabulated and are as 
shown in Table No: 11. 
%RSD Formula:  (σ /µ)*100 
Acceptance criteria: % Relative standard deviation (%RSD) for the areas of codeine 
phosphate, chlorpheniramine maleate and sodium benzoate from the standard 
chromatograms should not be more than 1.0 %. 
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3.3.4 SPECIFICITY: 
Specificity is the ability to assess unequivocally the analyte in the presence of 
components which may be expected to be present. Typically these might include 
impurities, degradants, matrix, etc. 
Procedure: 
Preparation of Standard solution (100µg/ml):  
  Accurately weigh and transfer 50mg of Codeine phosphate and 20mg of 
Chlorpheniramine maleate and 50mg of Sodium benzoate working standards into a 
100 ml volumetric flask, add about 70 ml of diluent and sonicate to dissolve it 
completely and make volume up to the mark with the same solvent. (Stock solution)   
Further pipette 5 ml of the above stock solution into a 25 ml volumetric flask 
and dilute up to the mark with diluent. Mix well and filter through 0.45µm filter. 
Inject 50 µl of blank solution into the HPLC system and chromatograph. 
Inject 50 µl of Standard solution for six times into the HPLC system and 
chromatograph. 
Compare the chromatograms visually and check for any interference. Calculate the 
average and relative standard deviation of area of codeine phosphate, 
chlorpheniramine maleate and sodium benzoate from standard chromatograms shown 
in Fig No: 21-27 and the results are tabulated and are as shown in Table No: 12. 
 %RSD for the area of six replicate injections is to be calculated using formula. 
%RSD Formula:  (σ /µ)*100 
Acceptance criteria: 
 There should not be any peak in the blank and Placebo solution run at the retention 
time corresponding to codeine phosphate, chlorpheniramine maleate and sodium 
benzoate as in standard run. 
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LINEARITY&RANGE: 
3.3.5 LINEARITY: 
The linearity of an analytical procedure is its ability (within a given range) to obtain 
test results which are directly proportional to the concentration (amount) of analyte in 
the sample. A linear relationship should be evaluated across the range of the analytical 
procedure by visual inspection of a plot of signals as a function of analyte 
concentration or content. If there is a linear relationship, test results should be 
evaluated by appropriate statistical methods, for example, by calculation of 
correlation coefficient, y-intercept, slope of the regression line and residual sum of 
squares. A plot of the data should be included. For the establishment of linearity, a 
minimum of five concentrations is recommended. 
3.3.6 RANGE: 
The range of an analytical procedure is the interval between the upper and lower 
concentration (amounts) of analyte in the sample (including these concentrations) for 
which it has been demonstrated that the analytical procedure has a suitable level of 
precision, accuracy and linearity. The specified range is normally derived from 
linearity studies and depends on the intended application of the procedure. It is 
established by confirming that the analytical procedure provides an acceptable degree 
of linearity, accuracy and precision when applied to samples containing amounts of 
analyte within or at the extremes of the specified range of the analytical procedure. 
Procedure:  
Preparation of Standard Stock Solution:  
       Accurately weigh and transfer 50 mg of Codeine phosphate, 20 mg of 
Chlorpheniramine maleate and 50 mg of Sodium benzoate working standards into a 
100 ml volumetric flask, add about 70 ml of diluent and sonicate to dissolve it 
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completely and make volume up to the mark with the same solvent. (Stock solution) 
          Preparation of (25, 50, 75, 100,125 and 150 µg/ml) sample solutions:  
 From the above stock solution pipette out 2.5,5.0,7.5,10.0,12.5,15.0 ml 
respectively into individual 50ml of volumetric flasks and dilute up to the mark with 
diluent to prepare 25,50,75,100,125,150 µg/ml of sample solutions respectively. Mix 
well and filter through 0.45µm filter.       
 Inject 50µl of blank solution and each linearity level standard solutions into 
the chromatographic system and measure the peak area. Plot a graph of peak area 
versus concentration (on X-axis concentration and on Y-axis Peak area) and calculate 
the correlation coefficient. The chromatograms corresponding to linearity are as 
shown in Fig No: 28-38 and the results are tabulated shown in Table No: 13-15. 
Formula: The equation for the correlation coefficient is: 
 
Regression line equation: y=mx+c 
                               Where, m = slope, c = y-intercept. 
Acceptance criteria for Linearity: 
      Correlation coefficient should not be less than 0.995. 
      Acceptance criteria for Range: 
      RSD for the areas of Linearity level-1 solution should not be more than 1.0%. 
      RSD for the areas of Linearity level-6 solution should not be more than 1.0%. 
3.3.7 ROBUSTNESS: 
The evaluation of robustness should be considered during the development phase and 
depends on the type of procedure under study. The robustness of an analytical 
procedure is a measure of its capacity to remain unaffected by small, but deliberate 
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variations in method parameters and provides an indication of its reliability during 
normal usage. 
 As part of the Robustness, deliberate change in the Flow rate, Mobile Phase 
composition and pH were made to evaluate the impact on the method. 
A) The flow rate was varied at 0.1 ml variation to normal flow rate of 1.5 ml. 
Preparation of Standard Solution (100µg/ml):  
Accurately weigh and transfer 50mg of Codeine phosphate and 20mg of 
Chlorpheniramine maleate and 50mg of Sodium benzoate working standards into a 
100 ml volumetric flask, add about 70 ml of diluent and sonicate to dissolve it 
completely and make volume up to the mark with the same solvent. (Stock solution)   
Further pipette 5 ml of the above stock solution into a 25 ml volumetric flask and 
dilute up to the mark with diluent. Mix well and filter through 0.45µm filter.       
          Inject 50µl of the blank solution and the standard solution of 100 µg/ml for five 
times and analysed using varied flow rates (1.4 ml, 1.6 ml) along with method flow 
rate and calculate the %RSD for the area of five replicate injections. The chromatograms 
are as shown in Fig No: 39 and the results are tabulated shown in Table No: 16. 
B) The pH of buffer solution in Mobile phase was varied at +/- 0.1 from normal pH of 
2.3. 
Preparation of Standard Solution (100µg/ml):  
Accurately weigh and transfer 50mg of Codeine phosphate and 20mg of 
Chlorpheniramine maleate and 50mg of Sodium benzoate working standards into a 
100 ml volumetric flask, add about 70 ml of diluent and sonicate to dissolve it 
completely and make volume up to the mark with the same solvent. (Stock solution)   
Further pipette 5 ml of the above stock solution into a 25 ml volumetric flask 
and dilute up to the mark with diluent. Mix well and filter through 0.45µm filter.       
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          Inject 50µl of the blank solution and the standard solution of 100 µg/ml for five 
times and analysed using the varied Mobile phase composition along with the actual 
mobile phase composition in the method and calculate the %RSD for the area of five 
replicate injections. The chromatograms are as shown in Fig No: 40 and the results are 
tabulated shown in Table No: 16. 
%RSD Formula:  (σ /µ)*100 
    Acceptance criteria: 
Relative standard deviation (RSD) of areas of codeine phosphate, chlorpheniramine 
maleate and sodium benzoate from five standard chromatograms in all the flow rate 
variation and mobile phase composition should not be more than 1.0 %. 
3.3.8 RUGGEDNESS: 
Ruggedness of the current method was demonstrated by analyzing six samples (assay) 
of syrup formulation by two analysts in the same laboratory. The RSD for the 12 
samples is calculated. 
Procedure: 
Preparation of Standard Solution (100µg/ml):  
Accurately weigh and transfer 50mg of Codeine phosphate and 20mg of 
Chlorpheniramine maleate and 50mg of Sodium benzoate working standards into a 
100 ml volumetric flask, add about 70 ml of diluent and sonicate to dissolve it 
completely and make volume up to the mark with the same solvent. (Stock solution)   
Further pipette 5 ml of the above stock solution into a 25 ml volumetric flask and 
dilute up to the mark with diluent. Mix well and filter through 0.45µm filter.       
         Inject the blank solution and standard solution of 100 µg/ml for six times and 
analysed by two analysts and calculate the %RSD for the area of twelve replicate 
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injections. The chromatograms are as shown in Fig No: 43, 44 and the results are 
tabulated shown in Table No: 17. 
%RSD Formula:  (σ /µ)*100 
    Acceptance criteria: 
Relative standard deviation (RSD) of areas of codeine phosphate, chlorpheniramine 
maleate and sodium benzoate from twelve standard chromatograms should not be more 
than 1.0 %. 
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4.1 RESULTS AND DISCUSSION 
In the present work a new method development and validation was carried out for the 
estimation of Codeine phosphate, Chlorpheniramine maleate and Sodium benzoate by 
RP-HPLC technique. The wavelength selection was made at 254 nm since all the 
selected drugs reported in various literatures were having a maximum absorbance at 
around 254 to 258 nm. Hence the wavelength was selected at 254 nm for the detection 
of the three compounds. 
4.1.1 METHOD DEVELOPMENT: For the method development several trials were 
carried out and reported. These lead to the optimized chromatographic conditions for 
the separation and estimation of Codeine phosphate, Chlorpheniramine maleate and 
Sodium benzoate in the bulk and marketed formulation. Preliminary studies involved 
trying ODS-silica columns and several mobile phase compositions for the effective 
separation of these three drugs.  By Zodiac C-18, 3.5µ,150×4.6mm column eluted 
with Solvent-A: Phosphate buffer pH-2.3, Solvent-B: Acetonitrile  by gradient elution 
pattern at a flow rate of 1.5 ml/ min and a detection wavelength of 254 nm with 
injection volume of 50 μl at Ambient(30°C) temperature afforded the best separation 
of these analytes. The chromatograms of trial methods were as shown in Fig.No:3-5 
and optimized method were as shown in Fig. No: 6-8. The assay results were as 
shown in Table No: 8.  
Results of Trial-1: RT’S were observed at 11.236(CP), 15.568(CPM) and the third 
peak is not eluted in 20 min runtime. Due to asymmetry in peaks and longer RT’s 
another trial is made with change in mobile phase-buffer pH. 
Results of Trial-2: RT’s were observed at 10.236(CP), 13.568(CPM) and the third 
peak is not eluted in 20 min runtime. Due to tailing in peaks and to further reduce 
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RT’s another trial is made with change in mobile phase-buffer pH, flow rate and 
elution pattern. 
Results of Trial-3(Final Optimized Method): RT’s were observed at 7.169(CP), 
9.480(CPM) and 10.860(SB). The peaks are sharply resolved with less tailing and 
hence the trial-3 method is optimized for analysis. 
Fig. No. 3: Chromatogram showing Trial-1. 
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Fig. No. 4: Chromatogram showing Trial-2. 
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Fig. No. 5: Chromatogram showing Trial-3. 
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Fig. No: 6 Chromatogram showing peaks of standard solution of Codeine 
phosphate, Chlorpheniramine maleate and Sodium benzoate. 
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Name Retention 
Time 
Area USP 
Resolution 
USP 
Tailing 
USP Plate 
Count 
Codeine phosphate 7.169 580770 1.0 16098.54 
Chlorpheniramine maleate 9.480 1024792 11.9 1.0 43143.60 
Sodium benzoate 10.860 723222 8.4 1.0 58871.82 
 
 
Fig. No.7:Chromatogram showing peaks of test solution of Codeine phosphate, 
Chlorpheniramine maleate and Sodium benzoate. 
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   Retention 
Time 
Area       USP     
Resolution 
USP 
Tailing 
USP Plate 
Count 
Codeine phosphate 7.148 580754 1.1 16091.54 
Chlorpheniramine maleate 9.469 1024782 11.7 1.0 43142.60 
Sodium benzoate 10.861 723225 8.6 1.0 58875.82 
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Fig. No. 8:Chromatogram showing overlay of Standard and Test samples of 
Codeine phosphate, Chlorpheniramine maleate and Sodium benzoate.   
 
 
 
 
            
Table No: 8 Table showing Assay Results of Codeine phosphate, 
Chlorpheniramine maleate and Sodium benzoate. 
S.No Compound name Assay value 
1. Codeine phosphate 99.2% 
2. Chlorpheniramine maleate 101.2% 
3. Sodium benzoate 99.8% 
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4.1.2 METHOD VALIDATION: 
After method development, the validation of the current method has been performed 
in accordance with USP requirements for assay determination (Category-I: analytical 
methods for quantitation of active ingredients in finished pharmaceutical products) 
which include accuracy, precision, selectivity, linearity and range, robustness and 
ruggedness. 
4.1.2.1 System Suitability Testing: 
System suitability testing is an integral part of many analytical procedures. System 
suitability test parameters like tailing factor, retention time, theoretical plates per unit, 
resolution factor are determined and the results are tabulated and are as shown in 
Table No: 9. 
 
 
Fig. No. 9: Chromatograms showing system suitability testing (INTRA DAY 
STUDIES) of Standard Solutions of codeine phosphate, chlorpheniramine 
maleate and sodium benzoate.  
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Table No: 9 Table showing list of system suitability parameters of codeine          
phosphate, chlorpheniramine maleate and sodium benzoate. 
Parameters Codeine 
phosphate 
Chlorpheniramine 
maleate 
Sodium 
benzoate 
Tailing factor 1.2 1.2 1.1 
Retention time 7.18 9.39 10.92 
Theoretical plates per unit 16779.2 43624.9 47472.4 
Resolution  2.9 2.02 
 
4.1.2.2 Accuracy (Recovery): 
Accuracy of the method was studied by preparing the placebo of the syrup 
formulation according to the formulation procedure. To the required quantity of 
placebo, a known quantity of the three active ingredients (codeine phosphate, 
chlorpheniramine maleate and sodium benzoate) with the same proportion as in the 
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drug formulation was added to get simulated drug formulation. The chromatograms 
are as shown in Fig. No: 10-12. The results are as shown in the Table No: 10 and the 
mean % recovery of the assay is within 100 ± 2.0% for each ingredient. These results 
show that the method was accurate. 
 
 
 
 
 
 
 
      
Fig. No. 10: Chromatogram showing Accuracy 50% of codeine phosphate, 
chlorpheniramine maleate and sodium benzoate. 
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Name Retention Time Area USP 
Resolution 
USP 
Tailing 
USP Plate 
Count 
Codeine phosphate 7.149 593890 1.1 11267.64 
Chlorpheniramine maleate 9.455 1053085 10.1 1.0 43121.69 
Sodium benzoate 10.858 727773 7.3 1.0 52097.67 
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Fig.No. 11: Chromatogram showing Accuracy -100% of codeine phosphate, 
chlorpheniramine maleate and sodium benzoate. 
C
od
ei
ne
 p
ho
sp
ha
te
 - 
7.
12
1
C
hl
or
ph
en
ira
m
in
e 
m
al
ea
te
 - 
9.
43
8
S
od
iu
m
 b
en
zo
at
e 
- 1
0.
85
2
AU
-0.02
0.00
0.02
0.04
0.06
0.08
0.10
0.12
0.14
0.16
0.18
0.20
0.22
0.24
Minutes
0.00 2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00
                    
Name Retention Time Area USP 
Resolution 
USP 
Tailing 
USP Plate 
Count 
Codeine phosphate 7.121 593882 1.1 11265.58 
Chlorpheniramine maleate 9.438 1053076 10.3 1.0 45121.72 
Sodium benzoate 10.852 727779 7.4 0.9 56097.54 
Fig. No. 12: Chromatogram showing Accuracy – 150% of codeine phosphate, 
chlorpheniramine maleate and sodium benzoate. 
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Name Retention Time Area USP 
Resolution 
USP 
Tailing 
USP Plate 
Count 
Codeine phosphate 7.105 593886 1.1 11264.52 
Chlorpheniramine maleate 9.430 1053082 10.5 1.0 45123.76 
Sodium benzoate 10.852 727765 7.1 1.0 46095.58 
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Table no: 10: Table showing results of % Recovery studies for Codeine 
phosphate, Chlorpheniramine maleate and Sodium Benzoate. 
4.1.2.3 Precision: 
The system precision of this method was evaluated by calculating the %RSD of the 
peak areas of six replicate injections of the standard solution, which were found to be 
0.41%, 0.35% and 0.37% and for method precision evaluated with six sample 
replicate injections were found to be 0.43%, 0.36% and 0.39% for codeine phosphate, 
chlorpheniramine maleate and sodium benzoate respectively and it was found to be 
less than 1.0% shown in the Table No: 11. The chromatograms were as shown in Fig. 
No: 13-20. These results show that the current method is repeatable and reproducible. 
               
 
 
 
Inj.sample 
Spike 
level 
Amount 
present 
Amount 
recovered 
%  
recovered 
  Mean 
recovery 
Acceptance 
Criteria 
Codeine Phosphate 
50 % 25mg     24.8mg 99.2% 
 
98.7% 
 
 
100 ± 2.0%100 % 50mg 49.8mg 99.6% 
150 % 75mg 75.07mg 100.1% 
Chlorpheniramine 
Maleate 
50 % 10mg 9.85mg      98.5% 
98.5%.5 
 
 
100 ± 2.0%
100 % 20mg 19.7mg 98.5% 
150 % 30mg 29.16mg 98.6% 
Sodium Benzoate 
50 % 25mg 24.72mg 98.9% 
 
99.1% 
 
 
 
100 ± 2.0%100 % 50mg 49.35mg 98.7% 
150% 75mg 74.4mg 99.2% 
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  Fig.No.13: Chromatogram showing Precision-blank solution. 
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Fig.No.14: Chromatogram showing Precision of Test sample Preparation-1 for 
codeine phosphate, chlorpheniramine maleate and sodium benzoate.                       
                              
 
 
  
 
 
 
 
 
 
 
Fig. No15: Chromatogram showing Precision of Test sample Preparation-2 for 
codeine phosphate, chlorpheniramine maleate and sodium benzoate. 
Name Retention Time Area USP 
Resolution 
USP 
Tailing 
USP Plate 
Count 
Codeine phosphate 7.148 593894  1.1 11261.55
Chlorpheniramine maleate 9.469 1053092 10.3 1.0 43123.64
Sodium benzoate 10.861 727768 7.5 1.0 46095.47
7.148
9.469
10.861
AU 
-0.02
0.00 
0.02 
0.04 
0.06 
0.08 
0.10 
0.12 
0.14 
0.16 
0.18 
0.20 
0.22 
0.24 
Minutes
0.00  2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00
Chapter 4                                                                                    Results And Discussion 
Rvs College of Pharmaceutical Sciences, Coimbatore  Page 86 
 
                                    
 
 
 
 
 
 
 
 
Fig. No.16: Chromatogram showing Precision of Test sample Preparation-3 for 
codeine phosphate, chlorpheniramine maleate and sodium benzoate.                       
 
Name Retention Time Area USP 
Resolution 
USP 
Tailing 
USP Plate 
Count 
Codeine phosphate 7.136 593890 1.1 11263.95
Chlorpheniramine maleate 9.457 1053086 10.2 1.0 45125.84
Sodium benzoate 10.853 727754 7.3 1.0 46092.54
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Fig. No. 17:  Chromatogram showing Precision of Test sample Preparation-4 for 
codeine phosphate, chlorpheniramine maleate and sodium benzoate.                      
 
 
 
 
 
 
 
 
 
 
 
 
 
Name Retention Time Area USP 
Resolution 
USP 
Tailing 
USP Plate 
Count 
Codeine phosphate 7.139 593887 1.1 11266.85 
Chlorpheniramine maleate 9.453 1053095 10.3 1.0 43127.64 
Sodium benzoate 10.856 727751 7.4 1.0 45095.52 
Name Retention Time Area USP 
Resolution 
USP 
Tailing 
USP Plate 
Count 
Codeine phosphate 7.137 593887  1.1 11266.75
Chlorpheniramine maleate 9.450 1053092 10.4 1.0 43129.94
Sodium benzoate 10.858 727762 7.2 1.0 45087.64
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Fig. No.18: Chromatogram showing Precision of Test sample Preparation-5 for 
codeine phosphate, chlorpheniramine maleate and sodium benzoate.                       
 
 
 
 
 
 
 
 
Fig. No.19: Chromatogram showing Precision of Test sample Preparation-6 for 
codeine phosphate, chlorpheniramine maleate and sodium benzoate.                       
 
 
 
Name Retention Time Area USP 
Resolution 
USP 
Tailing 
USP Plate 
Count 
Codeine phosphate 7.145 593896 1.1 11273.65 
Chlorpheniramine maleate 9.448 1053072 10.3 1.0 43135.84 
Sodium benzoate 10.848 727748 7.1 1.0 44082.74 
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Method Precision  
Fig.No.20: Chromatogram showing Method Precision of Codeine 
phosphate, Chlorpheniramine maleate, and Sodium Benzoate. 
 
Name Retention Time Area USP 
Resolution 
USP 
Tailing 
USP Plate 
Count 
Codeine phosphate 7.149 593880  1.1 11273.89 
Chlorpheniramine maleate 9.455 1053076 10.2 1.0 45095.84 
Sodium benzoate 10.858 727744 7.2 1.0 46097.56 
 
Table No: 11 Table showing Results of Precision for Codeine phosphate, 
Chlorpheniramine maleate and Sodium Benzoate. 
Parameter System Precision Method Precision 
Average 
Area 
Codeine 
phosphate 
Chlorpheniramine 
maleate 
Sodium 
benzoate
Codeine 
phosphate
Chlorpheniramine 
maleate 
Sodium 
benzoate
582985 1036039 719061 580118 1036157 713987 
SD 2390.2 3724.3 2719.3 2494.5 3812.9 2834.8 
%RSD 0.41 0.35 0.37 0.43 0.36 0.39 
 
 
 
Name Retention Time Area USP 
Resolution 
USP 
Tailing 
USP Plate 
Count 
Codeine phosphate 7.128 593898 1.1 11283.85 
Chlorpheniramine maleate 9.461 1053092 10.1 1.0 45135.54 
Sodium benzoate 10.865 727765 7.2 1.0 46082.94 
C
od
ei
ne
 p
ho
sp
ha
te
 - 
7.
14
9
C
hl
or
ph
en
ira
m
in
e 
m
al
ea
te
 - 
9.
45
5
S
od
iu
m
 b
en
zo
at
e 
- 1
0.
85
8
AU
-0.02
0.00
0.02
0.04
0.06
0.08
0.10
0.12
0.14
0.16
0.18
0.20
0.22
0.24
Minutes
0.00 2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00
Chapter 4                                                                                    Results And Discussion 
Rvs College of Pharmaceutical Sciences, Coimbatore  Page 90 
 
4.1.2.4 Specificity/Selectivity: 
Selectivity of the current method was demonstrated by good separation of the three 
analytes from each other, see Fig No:  Furthermore, excipients of the formulation did 
not interfere with the active ingredients of the drug product, as shown in the 
chromatograms. The average and relative standard deviation of area from standard 
chromatograms was calculated. The chromatograms are as shown in Fig. No:21-27 
and the results are as shown in Table No: 12 
Fig. No. 21: Chromatogram showing Specificity- Blank solution  
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Fig. No. 22: Chromatogram showing Specificity-Standard-1 solution of Codeine 
phosphate, Chlorpheniramine maleate and Sodium Benzoate. 
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Name Retention 
Time 
Area USP Resolution USP Tailing USP Plate 
Count 
Codeine phosphate 7.169 580770 1.0 16098.54
Chlorpheniramine maleate 9.480 1024792 11.9 1.0 43143.60
Sodium benzoate 10.860 723222 8.4 1.0 53871.82
 
 
Fig. No. 23: Chromatogram showing Specificity- Standard-2 solution of Codeine 
phosphate, Chlorpheniramine maleate and Sodium Benzoate. 
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Fig.No.24: Chromatogram showing Specificity- Standard-3 solution of Codeine 
phosphate, Chlorpheniramine maleate and Sodium Benzoate. 
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Name Retention Time Area USP 
Resolution 
USP 
Tailing 
USP Plate Count 
Codeine phosphate 7.163 566151 1.0 13652.01
Chlorpheniramine maleate 9.475 1023254 11.2 1.0 51711.86
Sodium benzoate 10.861 699694 8.0 1.0 57803.38
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Fig. No. 25: Chromatogram showing Specificity- Standard-4 solution of Codeine 
phosphate, Chlorpheniramine maleate, and Sodium Benzoate. 
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Fig. No. 26: Chromatogram showing Specificity- Standard-5 solution of Codeine 
phosphate, Chlorpheniramine maleate and Sodium Benzoate. 
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Name Retention 
Time 
Area USP 
Resolution 
USP Tailing USP Plate 
Count 
Codeine phosphate 7.159 584035 1.0 12409.89
Chlorpheniramine maleate 9.477 1031721 10.6 1.0 45450.64
Sodium benzoate 10.865 719025 7.5 1.0 51921.63
Name Retention Time Area USP 
Resolution 
USP 
Tailing 
USP Plate 
Count 
Codeine phosphate 7.155 590077 1.0 12264.39 
Chlorpheniramine maleate 9.473 1047339 10.8 1.0 48743.16 
Sodium benzoate 10.862 725587 7.6 1.0 51955.02 
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Name Retention Time Area USP 
Resolution 
USP 
Tailing 
USP Plate 
Count 
Codeine phosphate 7.150 593892 1.0 11267.77
Chlorpheniramine maleate 9.469 1053093 10.3 1.0 45121.66
Sodium benzoate 10.861 727778 7.2 1.0 46097.62
 
Fig. No. 27: Chromatogram showing Blank & Standard solution-1 overlay report 
of Codeine phosphate, Chlorpheniramine maleate and Sodium Benzoate. 
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Table No: 12 Table showing results of Specificity of Codeine phosphate, 
Chlorpheniramine maleate and Sodium Benzoate. 
 
4.1.2.5 & 4.1.2.6 Linearity and range: 
Linearity was studied from different concentrations of the three analytes in the range 
of 12.5-75 µg/ml for codeine phosphate, 5–30 µg/ml for chlorpheniramine maleate 
and 12.5-75 µg/ml for sodium benzoate and the linearity between the peak-area and 
the concentration was examined for each analyte. The chromatograms are as shown in 
Fig.No:28-38.The results obtained are shown in the Table No: 13-15 and show that 
the current method was linear for the three analytes in the range specified above with 
a correlation coefficient of better than 0.999. 
Parameter Codeine phosphate Chlorpheniramine 
maleate 
Sodium benzoate 
Average area 582964 1036045 719072 
SD 2389.5 3724.7 2719.5 
%RSD 0.40 0.38 0.39 
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Fig. No.28: Chromatogram showing Linearity level-1 (25%) of Codeine 
phosphate, Chlorpheniramine maleate and Sodium Benzoate. 
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Name Retention Time Area USP 
Resolution 
USP 
Tailing 
USP Plate 
Count 
Codeine phosphate 7.165 146517 1.1 2666.65 
Chlorpheniramine maleate 9.457 252347 10.2 1.0 10129.86 
Sodium benzoate 10.863 147150 7.1 1.1 11087.68 
 
 
Fig. No.29: Chromatogram showing Linearity level-2 (50%) of Codeine 
phosphate, Chlorpheniramine maleate and Sodium Benzoate.  
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Name Retention Time Area USP 
Resolution 
USP 
Tailing 
USP Plate 
Count 
Codeine phosphate 7.149 294820 1.1 5266.45 
Chlorpheniramine maleate 9.455 524063 10.1 1.0 21129.72 
Sodium benzoate 10.858 306740 7.2 1.0 21087.85 
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Fig.No.30:  Chromatogram showing Linearity level-3 (75%) of Codeine 
phosphate, Chlorpheniramine maleate and Sodium Benzoate. 
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Name Retention Time Area USP 
Resolution 
USP 
Tailing 
USP Plate 
Count 
Codeine phosphate 7.141 446999 1.1 3562.86 
Chlorpheniramine maleate 9.460 792940 10.3 1.0 16129.42 
Sodium benzoate 10.861 470036 7.1 1.1 17087.65 
 
 
Fig. No. 31: Chromatogram showing Linearity level-4 (100%) of Codeine 
phosphate, Chlorpheniramine maleate and Sodium Benzoate. 
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Name Retention Time Area USP 
Resolution 
USP 
Tailing 
USP Plate 
Count 
Codeine phosphate 7.121 595115 1.1 12264.39 
Chlorpheniramine maleate 9.438 1063971 10.4 1.0 48743.16 
Sodium benzoate 10.852 626825 7.2 1.0 51955.02 
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Fig. No. 32: Chromatogram showing Linearity level-5 (125%) of Codeine 
phosphate, Chlorpheniramine maleate and Sodium Benzoate. 
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Name Retention Time Area USP 
Resolution 
USP 
Tailing 
USP Plate 
Count 
Codeine phosphate 7.117 748334 1.1 14867.35 
Chlorpheniramine maleate 9.435 1342834 10.5 1.0 50179.26 
Sodium benzoate 10.857 779389 7.2 1.1 51087.86 
 
 
Fig. No. 33: Chromatogram showing Linearity level-6 (150%) of Codeine 
phosphate, Chlorpheniramine maleate and Sodium Benzoate. 
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Name Retention Time Area USP 
Resolution 
USP 
Tailing 
USP Plate 
Count 
Codeine phosphate 7.105 898406 1.1 176862.65 
Chlorpheniramine maleate 9.423 1618163 10.1 1.0 521624.81 
Sodium benzoate 10.852 936540 7.3 1.1 521087.45 
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Fig. No. 34: Chromatogram showing overlay of Linearity levels of Codeine 
phosphate, Chlorpheniramine maleate and Sodium Benzoate. 
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Table No: 13 Table showing linearity result for Codeine phosphate. 
For Codeine phosphate: 
Linearity Level Concentration (µg/mL) Area 
1 25 146517 
2 50 294820 
3 75 446999 
4 100 595115 
5 125 748334 
6 150 898406 
Correlation Coefficient 0.999991 
 
Fig.No.35: Figure showing Linearity graph of Codeine phosphate. 
 
 
The correlation coefficient value was found to be 0.999991. 
 
 
 
 
Chapter 4                                                                                    Results And Discussion 
Rvs College of Pharmaceutical Sciences, Coimbatore  Page 99 
 
Table no: 14 Table showing linearity results for Chlorpheniramine maleate. 
For Chlorpheniramine maleate: 
Linearity Level Concentration (µg/ml) Area 
1 5 252347 
2 10 524063 
3 15 792940 
4 20 1063971 
5 25 1342834 
6 30 1618163 
Correlation Coefficient 0.999980 
 
Fig. No.36: Figure showing linearity graph of Chlorpheniramine maleate. 
 
 
The correlation coefficient value was found to be 0.999980. 
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Table no: 15 Table showing linearity results for Sodium benzoate. 
For Sodium benzoate: 
Linearity Level Concentration (µg/ml) Area 
1 12.5 147150 
2 25 306740 
3 37.5 470036 
4 50 626825 
5 62.5 779389 
6 75 936540 
Correlation Coefficient 0.999943 
 
Fig. No.37: Figure showing linearity graph of Sodium benzoate. 
 
 
The correlation coefficient value was found to be 0.999943. 
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Fig.No.38: Figure showing Linearity graph of Codeine Phosphate, 
Chlorpheniramine Maleate and Sodium Benzoate in comparison. 
 
 
 
 
The correlation coefficient values were found to be with in the acceptance limits for 
Codeine Phosphate, Chlorpheniramine Maleate and Sodium Benzoate. 
4.1.2.7 Robustness: 
Robustness of the current method was investigated by analyzing samples of the drug 
product using the same chromatographic conditions set forth in method development 
but with a small change in the following chromatographic parameters: 
 (a) Flow rate: 1.4 and 1.6 ml/min instead of 1.5 ml/min, 
 (b) pH of the buffer preparation in mobile phase: 2.2 and 2.4 instead of 2.3. 
 %RSD of Codeine phosphate, Chlorpheniramine maleate and Sodium benzoate assay 
under these conditions is calculated and the results are shown in Table No: 16. The 
chromatograms are as shown in Fig. No: 39, 40. 
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A) Flow variation-1 (1.4mL/min): 
Fig.No.39:  Chromatogram showing Robustness-Flow variation (1.4ml/min) of 
Codeine phosphate, Chlorpheniramine maleate and Sodium Benzoate. 
 Standard solution-1: 
 
 
 
 
 
 
 
Standard solution-2: 
 
 
 
 
Name Retention 
Time 
Area USP 
Resolution 
USP 
Tailing 
USP Plate 
Count 
Codeine phosphate 7.422 580770  1.1 16098.54
Chlorpheniramine maleate 9.638 1024792 11.9 1.0 58143.60
Sodium benzoate 11.105 723222 8.4 1.2 63871.82
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Standard solution-3: 
 
 
 
 
 
 
Standard solution-4: 
 
 
 
 
 
Name Retention 
Time 
Area USP 
Resolution 
USP 
Tailing 
USP Plate 
Count 
Codeine phosphate 7.411 600775 1.0 16065.84 
Chlorpheniramine maleate 9.645 1024795 11.8 1.0 58145.90 
Sodium benzoate 11.118 723287 8.5 1.2 63878.12 
Name Retention 
Time 
Area USP 
Resolution 
USP 
Tailing 
USP Plate 
Count 
Codeine phosphate 7.429 610720 1.0 16097.94 
Chlorpheniramine maleate 9.630 11247986 11.9 1.0 58149.80 
Sodium benzoate 11.100 723265 8.4 1.2 63876.72 
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Standard solution-5: 
 
 
 
 
 
 
B) Flow variation-2 (1.6mL/min): 
Fig. No. 40: Chromatogram showing Robustness-Flow variation (1.6ml/min) of Codeine 
phosphate, Chlorpheniramine maleate and Sodium Benzoate. 
Standard solution-1: 
 
 
 
 
Name Retention 
Time 
Area USP 
Resolution 
USP 
Tailing 
USP Plate 
Count 
Codeine phosphate 7.425 598670 1.0 16098.52 
Chlorpheniramine maleate 9.645 1024892 11.8 1.0 57143.56 
Sodium benzoate 11.101 723252 8.6 1.2 62871.85 
Name Retention 
Time 
Area USP 
Resolution 
USP 
Tailing 
USP Plate 
Count 
Codeine phosphate 7.417 610770  1.0 15998.54
Chlorpheniramine maleate 9.31 1014792 12.1 1.0 59043.60
Sodium benzoate 11.098 713222 8.7 1.2 64271.82
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Standard solution-2: 
 
 
 
 
 
 
 
Standard solution-3: 
 
 
 
 
 
 
Name Retention 
Time 
Area USP 
Resolution 
USP 
Tailing 
USP Plate 
Count 
Codeine phosphate 6.871 578798 1.1 16128.54 
Chlorpheniramine maleate 9.244 1024769 11.8 1.0 58033.10 
Sodium benzoate 10.631 723354 8.6 1.0 63872.42 
Name Retention 
Time 
Area USP 
Resolution 
USP 
Tailing 
USP Plate 
Count 
Codeine phosphate 6.875 578760 1.1 15998.94 
Chlorpheniramine maleate 9.249 1024782 11.8 1.0 58146.86 
Sodium benzoate 10.630 723232 8.2 1.0 63874.85 
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Standard solution-4: 
 
 
 
 
 
 
Standard solution-5: 
 
 
 
 
 
 
Name Retention 
Time 
Area USP 
Resolution 
USP 
Tailing 
USP Plate 
Count 
Codeine phosphate 6.868 581765 1.1 16084.67 
Chlorpheniramine maleate 9.240 1024789 11.7 1.0 58156.80 
Sodium benzoate 10.635 723231 8.6 1.0 63869.92 
Name Retention 
Time 
Area USP 
Resolution 
USP 
Tailing 
USP Plate 
Count 
Codeine phosphate 6.879 580675  1.2 16076.84
Chlorpheniramine maleate 9.238 1024787 12.0 1.0 58155.90
Sodium benzoate 10.645 723232 8.8 1.1 63873.62
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C) PH variation-1 (2.2): 
Fig.No.41:  Chromatogram showing Robustness- PH variation (2.2) of Codeine 
phosphate, Chlorpheniramine maleate and Sodium Benzoate. 
 Standard solution: 
 
 
 
 
 
 
 
 
 
 
 
 
Name Retention 
Time 
Area USP 
Resolution 
USP 
Tailing 
USP Plate 
Count 
Codeine phosphate 6.865 580762  1.1 16082.54
Chlorpheniramine maleate 9.240 1024785 11.7 1.0 58145.60
Sodium benzoate 10.629 723227 8.6 1.0 63876.82
Name Retention 
Time 
Area USP 
Resolution 
USP 
Tailing 
USP Plate 
Count 
Codeine phosphate 7.422 580770 1.1 16098.54 
Chlorpheniramine maleate 9.638 1024792 11.9 1.0 58143.60 
Sodium benzoate 11.105 723222 8.4 1.2 63871.82 
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D) PH variation-2 (2.4): 
Fig.No.42:  Chromatogram showing Robustness- PH variation (2.4) of Codeine 
phosphate, Chlorpheniramine maleate and Sodium Benzoate. 
 Standard solution: 
 
 
 
 
 
 
Name Retention 
Time 
Area USP 
Resolution 
USP 
Tailing 
USP Plate 
Count 
Codeine phosphate 6.871 578798 1.1 16128.54 
Chlorpheniramine maleate 9.244 1024769 11.8 1.0 58033.10 
Sodium benzoate 10.631 723354 8.6 1.0 63872.42 
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Table No: 16 Table showing Robustness results for change in flow rate and pH of 
Codeine phosphate, Chlorpheniramine maleate and Sodium Benzoate. 
 
4.1.2.8 Ruggedness: 
Ruggedness of the current method was demonstrated by analyzing three samples 
(assay) of syrup formulation by two analysts in the same laboratory on two different 
days. The %RSD values for the 12 samples are calculated to be 0.42%, 0.62%, and 
0.49% for codeine phosphate, chlorpheniramine maleate and sodium benzoate 
respectively. The chromatograms are as shown in Fig.No:41, 42 and the results are as 
shown in the Table No: 17 indicating the ruggedness of the method. 
 
 
 
Fig. No. 43: Chromatogram showing Ruggedness: Day-1, Analyst-1 of Codeine 
phosphate, Chlorpheniramine maleate and Sodium Benzoate. 
Flow rate Inj.sample  Plate count Tailing RT %RSD 
 
1.4ml/min 
Codeine phosphate      16098.54 1.0 7.148 0.42 
Chlorpheniramine maleate 58143.60 1.04 9.469 0.36 
Sodium benzoate 63871.82 1.1 10.86 0.38 
 
1.6ml/min 
Codeine phosphate 13652.01 1.23 7.105 0.40 
Chlorpheniramine maleate 51711.86 1.0 9.420 0.35 
Sodium benzoate 57803.38 1.0 10.85 0.37 
pH variation      
 
2.2 
Codeine phosphate     17779.21 1.2 7.180 0.41 
Chlorpheniramine maleate 52624.93 1.2 9.394 0.37 
Sodium benzoate      71472.43 1.1 10.923 0.39 
 
2.4 
Codeine phosphate      17768.98 1.1 7.165 0.45 
Chlorpheniramine maleate 52628.56 1.0 9.35 0.33 
Sodium benzoate 71470.75 1.0 10.910 0.40 
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Name Retention Time Area USP Resolution USP 
Tailing 
USP Plate 
Count 
Codeine phosphate 7.169 566151 1.0 13652.01 
Chlorpheniramine maleate 9.480 1023254 11.2 1.0 51711.86 
Sodium benzoate 10.860 699694 8.0 1.0 57803.38 
 
Fig. No.44: Chromatogram showing Ruggedness: Day-2, Analyst-2 of Codeine 
phosphate, Chlorpheniramine maleate and Sodium Benzoate. 
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Name Retention Time Area USP Resolution USP 
Tailing 
USP Plate 
Count 
Codeine phosphate 7.001 566151 1.0 13658.61 
Chlorpheniramine maleate 9.283 1023254 10.8 1.1 51715.96 
Sodium benzoate 10.860 699694 7.8 1.0 57823.28 
 
Chapter 4                                                                                    Results And Discussion 
Rvs College of Pharmaceutical Sciences, Coimbatore  Page 111 
 
Table No: 17 Table showing Ruggedness results of Analysts-1&2 on Days-1&2 of 
Codeine phosphate, Chlorpheniramine maleate and Sodium Benzoate. 
 ANALYST-1 
 DAY-1 DAY-2 
A.I CP CPM SB CP CPM SB 
1. 593892 1024792 727778 584035 1047999 725842 
2. 593436 1023254 735642 592456 1036824 724689 
3. 593945 1025256 731028 586945 1047642 723688 
Mean 593757 1024434 731482 587812 1044155 734739 
SD 2796.98 1047.9 3159.6 4276.9  6351.3 1077.8 
%RSD 0.40 0.103 0.54 0.72 0.61 0.15 
 
 
 ANALYST-2 
 DAY-1 DAY-2 
A.I CP CPM SB CP CPM SB 
1. 590077 1053039 723222 591486 1052786 725846 
2. 584628 1048958 724674 587628 1058462 725486 
3. 587463 1035478 723654 584968 1059466 735644 
Mean 587389 1045825 723850 588027 1056904 728992 
SD 2725.2 9190.15 745.57 3277.3 3602.02 5763.6 
%RSD 0.46 0.87 0.103 0.55 0.34 0.79 
. 
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4.2 SUMMARY AND CONCLUSION 
A new method of analysis is developed for identification and quantification of 
Codeine phosphate, Chlorpheniramine maleate drugs and Sodium benzoate 
preservative by RP-HPLC method. The sample preparation is simple and the analysis 
time is short. The analytical procedure is validated as per ICH Q2B guidelines and 
shown to be accurate, precise and specific.  
This method represents a fast analytical procedure for the simultaneous 
quantitation of Codeine phosphate, Chlorpheniramine maleate and Sodium benzoate. 
The method is amenable to the routine analysis of large numbers of samples with 
good precision and accuracy. 
 
 
Chapter 5                                                                                                     Bibliography 
Rvs College Of Pharmaceutical Sciences, Coimbatore  Page 114 
5. BIBLIOGRAPHY 
1. Sethi.PD. HPLC Quantitative analysis of pharmaceutical formulations, Ed-1st, 
CBS Publishers and distributors, New Delhi, 2001, pp: 94-105. 
2. Glajch L, Kirkaland J and Snyder R. Practical HPLC method development, 
Ed-2nd, John Wiley and sons, INC,New York, 1999, pp: 234-260. 
3. Ashutoshkar S. Pharmaceutical Drug Analysis, Ed-2nd, New age international 
(p) limited publishers, 2005, pp: 452-474. 
4. http://en.wikipedia.org/wiki/Chromatography. 
5. U.S.P. Asian Edition, United Pharmacopoeial Convention Inc, Rockville, 
2005, pp: 2386-2389. 
6. James.W Munson. Modern Methods of Pharmaceutical Analysis, Medical 
Book Distributors, Mumbai, 2001, pp: 17-54. 
7. Sethi P.D. High Performance Liquid Chromatography and Quantitative 
analysis Pharmaceutical Formulations, Ed-1st, CBS Publishers and 
Distributors, 2001, pp: 3-5. 
8. Erwing, G. W. Instrumental Methods of Chemical Analysis, Ed-2nd , McGraw 
Hill  Book    Company, 1960,  pp: 3-5. 
9. GurdeepR.Chatwal and Sham K.Anand. Instrumental Methods of Chemical 
Analysis, Ed-5th, Himalaya Publishing House, pp: 1.2 – 1.5. 
10. Sharma B.K. Instrumental Method of Chemical Analysis, Ed-23rd , Goal 
publication House, 1991, Merrut, pp: 7-10. 
11. RamaRao, G.Murthy, S.S.N and Khadgapathi P. High Performance Liquid 
Chromatograpy and its role in pharmaceutical analysis, Eastern Pharmacist, 
1986, 20 (346), pp: 53-59. 
Chapter 5                                                                                                     Bibliography 
Rvs College Of Pharmaceutical Sciences, Coimbatore  Page 115 
12. Sastry C.S.P., Prasad T.N.V. and Rao E.V. Recent application of High 
Performance Liquid Chromatography in Pharmaceutical Analysis, Indian. 
Pharm. Education, 1987, 21, pp: 37-40. 
13. Loyd. K. Snyder, Joseph. J. Kirkland and joseph. L. Glajch. Practical HPLC 
Method Development, Ed-2nd, Wiley – Interscience Publication, USA, pp: 
742-747. 
14. Willard, H.Y. Merritt L.L., Dean J.A. and Settle F.A. Instrumental Methods of  
Analysis, Ed-7th, CBS Publishers and Distributors, New Delhi,1991, pp: 436-
439. 
15. The International Conference on Harmonization (ICH)-Validation of 
Analytical Procedures: Methodology (Q2B), Food and Drug Administration, 
USA, Nov.1996. 
16. http://en.wikipedia.org/wiki/Codeine_phosphate. 
17. http://en.wikipedia.org/wiki/Chlorpheniramine_maleate. 
18. http://en.wikipedia.org/wiki/Sodium_benzoate. 
19. Fuad Al-Rimawi. Normal-phase LC method for simultaneous analysis of 
pseudophedrine hydrochloride, dextromethorphan hydrobromide, 
chlorpheniramine maleate and paracetamol in tablet formulations. Saudi 
Pharmaceutical Journal. 2010; 18(2): 103-106.  
20. Mukesh Maithani, Richa Raturi, Vertika Gautam, Dharmendra Kumar, 
Amrendra Kumar Chaudhary, Anand Gaurav and Ranjit Singh. Development 
And Validation Of A Rp-Hplc Method For The Determination Of 
Chlorpheniramine Maleate And Phenylephrine In Pharmaceutical Dosage 
Form. International Journal of Comprehensive Pharmacy.2010; 01(05):1-4. 
Chapter 5                                                                                                     Bibliography 
Rvs College Of Pharmaceutical Sciences, Coimbatore  Page 116 
21. Adnan Manassra , Mustafa Khamis, Magdy el-Dakiky, Zuhair Abdel-Qader 
and Fuad Al-Rimawi. Simultaneous HPLC analysis of pseudophedrine 
hydrochloride, codeine phosphate and triprolidine hydrochloride in liquid 
dosage forms. Journal of Pharmaceutical and Biomedical Analysis.2010; 
51(4):991-993. 
22. Ezzat M. Abdel-Moety. Selective Hplc-quantification of promethazine 
Hydrochloride and its degradation products In presence of sodium benzoate. 
Saudi Pharmaceutical Journal. 2009; 17(2):161-169.  
23. Aravindaraj Joghee Rajua. Development and Application of a Validated 
Liquid Chromatography-Mass Spectrometry Method for the Determination of 
Dexchlorpheniramine Maleate in Human Plasma. Iranian Journal of 
Pharmaceutical Sciences.2007; 3(3):161-170. 
24. Maria-Elisa Capella-Peiro. Optimization of a capillary zone electrophoresis 
method by using a central composite factorial design for the determination of 
codeine and paracetamol in pharmaceuticals. Journal of Chromatography 
B.2006; 839(1-2):95-101. 
25. Maria R. Gomez. Development and validation of a capillary electrophoresis 
method for the determination of codeine, diphenhydramine, ephedrine and 
noscapine in pharmaceuticals. Il Farmaco.2005; 60(1):85-90. 
26. V.Galli. High performance liquid chromatographic analysis of 
dextromethorphan, guaifenesin and benzoate in a cough syrup for stability 
testing. Journal of Chromatography A.2004; 108(2):207-211. 
27. Mohsen Kompany-Zareh. Spectrophotometric resolution of ternary mixtures 
of pseudoephedrine hydrochloride, dextromethorphan hydrobromide, and 
sodium benzoate in syrups using wavelength selection by net analyte signals 
Chapter 5                                                                                                     Bibliography 
Rvs College Of Pharmaceutical Sciences, Coimbatore  Page 117 
calculated with hybrid linear analysis. Analytica Chimica Acta.2004; 
526(1):83-94. 
28. A.Garcia. Poly(ethyleneglycol) column for the determination of 
acetaminophen, phenylephrine and chlorpheniramine in pharmaceutical 
formulations. Journal of Chromatography B.2003; 785(2):237-243. 
29. Darryl J. Hood. A chromatographic method for rapid and simultaneous 
analysis of codeine phosphate, ephedrine HCl and chlorpheniramine maleate 
in cough–cold syrup formulation. Journal of Pharmaceutical and Biomedical 
Analysis.2003; 30(5):1595-1601. 
30. A.Marin. Validation of a HPLC quantification of acetaminophen, 
phenylephrine and chlorpheniramine in pharmaceutical formulations: capsules 
and sachets. Journal of Pharmaceutical and Biomedical Analysis.2002; 29(4): 
701-714. 
31. Murat Kartal. LC method for the analysis of paracetamol,caffeine and codeine 
phosphate in pharmaceutical preparations. Journal of Pharmaceutical and 
Biomedical Analysis.2001; 26(5-6):857-864. 
32. Ruby Ragonese. Full and fractionated experimental designs for robustness 
testing in the high-performance liquid chromatographic analysis of codeine 
phosphate, pseudoephedrine hydrochloride and chlorpheniramine maleate in a 
pharmaceutical preparation. Journal of Chromatography A.2000; 870(1-2):45-
51. 
33. Io-Wah Lau. High-performance liquid chromatographic determination of 
active ingredients in cough-cold syrups with indirect conductometric 
detection. Journal of Chromatography A.1995; 693(17):45-54. 
Chapter 5                                                                                                     Bibliography 
Rvs College Of Pharmaceutical Sciences, Coimbatore  Page 118 
34. Brianne Weingarten. Determination of codeine in human plasma by high-
performance liquid chromatography with fluorescence detection. Journal of 
Chromatography A.1995; 696(1):83-92. 
35. G. Santoni. Simultaneous determination of aspirin, codeine phosphate and 
propyphenazone in tablets by reversed-phase high-performance liquid 
chromatography. International Journal of Pharmaceutics.1992; 80(1-3):263-
266. 
36. Zhao Rong Chen. Simultaneous determination of codeine, norcodeine and 
morphine in biological fluids by high-performance liquid chromatography 
with fluorescence detection. Journal of Chromatography B.1989; 491:367-
378. 
37. O. W. Lau. The simultaneous determination of active ingredients in cough-
cold mixtures by isocratic reversed-phase ion-pair high-performance liquid 
chromatography. Journal of Pharmaceutical and Biomedical Analysis.1989; 
7(6):725-736. 
38. Ron Ginman. Simultaneous determination of codeine and ibuprofen in plasma 
by high-performance liquid chromatography. Journal of Pharmaceutical and 
Biomedical Analysis.1985; 3(5):439-445. 
 
 
 
 
 
